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The internal surface of the lung is covered by alveolar epithelial type I (ATI) and II
(ATII) cells. In response to injury ATII cells proliferate and transdifferentiate to ATI
cells. Currently, there are no simple methods to identify transdifferentiation in vivo.
This study used a novel combination of ATI and ATII cell-selective antibodies to
investigate the phenotype of the alveolar epithelium following Staphylococcus aureus-
induced 'direct' lung injury. Imaging using confocal laser scanning microscopy with 2D
and 3D image analysis allowed qualitative and quantitative investigation of the
epithelial response to injury. Following distal airway instillation of S. aureus, the
alveolar epithelium was covered with ATII cells (MMC4/RTII70-positive cells) and ATI
cells (RTI40-positive cells) as seen in control lungs. However, the surface area covered
by ATII cells was significantly increased, while the surface area covered by ATI cells
was significantly decreased, in comparison with controls. Ultrastructural studies
confirmed the decrease in ATI cell numbers following S. aMrews-inoculation. The
alveolar wall of S. awrews-injured lungs also contained cells that co-stained with a
unique combination of ATI and ATII cell proteins, RTI40 and MMC4. To determine
whether RTI40/MMC4-positive cells were likely to be intermediates in the transition of
ATII to ATI cells I examined ATII cells as they transformed to ATI-like cells in culture
(day 0 to 5). Only cells on day 1 of culture were RTI^/MMX^l positive. I also examined
the developing lung for RTI^/MMCd positive cells. Co-staining cells were not found in
the developing alveolar epithelium, but they were present in small airways. I also
developed a rat model of haemorrhagic shock induced 'indirect' alveolar epithelial
injury as a platform for future work. Here I have developed a robust technique for
imaging ATII cell transdifferentiation in vivo and in vitro. This work has identified a
novel alveolar epithelial phenotype, RTI40/MMC4, in repairing lungs and in ATII cells
as they transdifferentiate to ATI-like cells in vitro. These data suggest that
RTI40/MMC4-positive cells can be used to both visualize alveolar epithelial
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Introduction
Defining the problem - Acute Lung Injury and Acute Respiratory Distress
Syndrome
Ashbaugh and colleagues published the first description of 'Respiratory Distress
Syndrome' in the Lancet in 1967 (Ashbaugh, Bigelow et al. 1967). They describe 12
patients with a pattern of acute dyspnoea, cyanosis refractory to oxygen therapy and
loss of lung compliance. These clinical features were accompanied by 'diffuse alveolar
infiltration' on chest X-ray and a mortality of nearly 60% (7/12). In speculating on the
possible pathogenesis of the syndrome the authors postulate 'a common mechanism of
injury' to explain the stereotyped end-point after a variety of stimuli. Reflecting on the
possible cause of loss of lung compliance, refractory cyanosis and microscopic
atelectasis they implicate the alveolus as 'a likely source of trouble.'(Ashbaugh,
Bigelow et al. 1967).
Since these initial comments by Ashbaugh and colleagues much has been discovered
about the 'Acute Respiratory Distress Syndrome' (ARDS). A key instrument in
facilitating the collection of epidemiological data, and allowing comparison of clinical
trial data, has been the widespread adoption of a standard definition of ARDS. In 1994
the American-European Consensus Conference Committee on ARDS agreed that the
term 'acute lung injury' (ALI) could be applied to a 'wide spectrum' of the clinical
presentations of this condition, but that the term 'acute respiratory distress syndrome' be
reserved for the most severe end of this spectrum (Bernard, Artigas et al. 1994).
Therefore, 'all patients with ARDS have ALI, but not all patients with ALI have a
ARDS' (Bernard, Artigas et al. 1994). The 1994 Consensus committee defined ALI as a
syndrome of inflammation with injury to the air-blood barrier. The group offered a list
of common precipitants, citing sepsis syndrome, aspiration, primary pneumonia and
multiple trauma as the commonest (table 1). The committee further recommended
operational criteria for the identification of patients with ALI and ARDS (table 2).
Although the simplicity of this definition has its detractors, as it does not include
assessment of the many factors influencing outcome from ALI and ARDS (e.g.
underlying cause, dysfunction of other organ systems), it has improved the
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standardisation of clinical research and trials (Ware and Matthay 2000).
Table 1. Clinical disorders associated with development of ARDS, as identified by
the American-European Consensus Conference Committee on ARDS 1994
(Bernard, Artigas et al. 1994).
I. Direct Injury II. Indirect Injury
Aspiration Sepsis syndrome, with or without hypotension
Diffuse pulmonary infection Severe non-thoracic trauma
Near drowning Hypertransfusion for emergency resuscitation
Toxic inhalation Cardiopulmonary bypass (rare)
Lung contusion
Table 2. Recommended criteria for ALI and ARDS, American-European






























The extent of the problem - incidence of ALI/ARDS
Accurate assessment of disease incidence is fundamental to estimating the societal
burden of a disease, tracking trends, and informing decisions regarding allocation of
research money and resources. Estimates of the incidence of ALI and ARDS have
varied significantly, from 75 per 100,000 person-years (105 person-years) in an early
study from the USA (National Institutes of Health 1977), to between 1.5 and 8.3 per 105
person-years in more recent studies from the UK and USA (Webster, Cohen et al. 1988;
Villar and Slutsky 1989; Thomsen and Morris 1995). Figures vary according to
definitions employed, methodological assumptions made and the populations studied.
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The first published study employing the 1994 consensus definitions reported
Scandinavian figures of 17.9 per 105 person-years for ALI and 13.5 per 105 person-years
for ARDS. As definitions and methodology have become increasingly standardised, a
recent study utilising the screening logs of the multi-centre Acute Respiratory Distress
Syndrome Network (ARDSnet) randomized trial and data from the American Hospital
Association has estimated the annual incidence of ALI/ARDS in the USA as 64.2 per
105 person-years (Goss, Brower et al. 2003). Corroborative estimates of the likely
incidence of ARDS can be derived by examining the incidence of the commonest
aetiological factors (i.e. sepsis, pneumonia and severe trauma) and combining these
figures with epidemiological data indicating what proportion of these patients will go on
to develop ARDS. Rubenfeld and Neff have performed this exercise and estimate an
incidence of ARDS associated with sepsis of 45-64 cases per 105 person-years and with
severe trauma (injury severity score > 15) of 11-18 per 105 person-years (Rubenfeld
2003). They also point to further sources corroborating these higher incidence rates
(Rubenfeld 2003). Armed with this estimate of incidence for the disease, and assuming
a mortality rate of approximately 40% (consistent with the recent literature - see below)
the authors then go on to calculate the Attributable Mortality for ALI by multiplying
these two values, giving a figure for the USA of around 17,000 - 43,000 deaths per year
(Rubenfeld 2003). This figure is put into context with other diseases having important
public health impact in table 3.
Table 3. Attributable mortality for acute lung injury and comparison diseases
(adapted from (Rubenfeld 2003))
Disease Attributable Mortality
ALI 17,000-43,000
Acute respiratory failure 60,000-120,000





The severity of the problem - outcomes after ALI/ARDS
Until recently, perhaps the most disappointing aspect of the study of ALI/ARDS was
the fact that in over three decades since it was first described, there had been little
change in the reported mortality rate. Most studies report a mortality rate of 40 - 60
percent (Bell, Coalson et al. 1983; Fowler, Hamman et al. 1983; Montgomery, Stager et
al. 1985; Suchyta, Clemmer et al. 1992; Doyle, Szaflarski et al. 1995; Heffner, Brown et
al. 1995; Milberg, Davis et al. 1995; Zilberberg and Epstein 1998). Recently studies
have begun to report a decline in mortality. Milberg et al reported a steady improvement
in outcome beginning in 1989 with mortality reaching a low of 36% in 1993 (Milberg,
Davis et al. 1995). Similarly, in the UK Abel et al. found a decrease in mortality from
66% in 1990-93 to 34% in 1993-97 (Abel, Finney et al. 1998). These gradual changes in
mortality do not appear to reflect the success of a particular therapy, but rather a non¬
specific improvement in the delivery of ICU care (Abel, Finney et al. 1998). Indeed, a
recent systematic review of therapies for ALI and ARDS found that the evidence does
not support the use of any specific pharmacological intervention (Adhikari, Burns et al.
2004). Most encouragingly, the ARDSnet trial, comparing ventilatory strategies used in
the support of patients with ARDS reported a mortality rate of 31% in patients treated
with low tidal volume ventilation (i.e. 6ml per kg body weight compared to a traditional
12ml per kg body weight) (2000).
In the majority of cases of ARDS death is attributed to sepsis or multi organ failure -
rather than primary respiratory failure. It is likely, however, that lung dysfunction
contributes significantly to these processes. Pulmonary dysfunction in ALI/ARDS
usually necessitates mechanical ventilation, which is not only a potential cause of
further lung injury (Dreyfuss and Saumon 1998), but also predisposes to pulmonary
infection (Kollef 1999; Bonten, Kollef et al. 2004), and results in a systemic
inflammatory response which could worsen extra-pulmonary organ dysfunction
(Slutsky and Tremblay 1998; Ranieri, Giunta et al. 2000). The 2000 ARDSnet trial also
lends empirical support to the concept of 'injurious' ventilation. This landmark study
showed not only a reduction in absolute mortality of around 10% with low tidal volume
ventilation, but also an increase in days free from multi-organ failure (MOF) -
suggesting that mechanical ventilation has played a significant part in the pathogenesis
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of ARDS as well its treatment.
Alveolar epithelial cell injury is a crucial component of ALI
The pathological process affecting the lung after a range of injurious events can be
described as occurring in a series of stages (Albertine 1998). Acutely, extensive
endothelial and epithelial damage cause airspace flooding during the first few days
(<7days) after the onset of injury. This has also been termed the 'exudative' phase
(Tomashefski 2003). The alveoli are filled with protein rich exudate, inflammatory cells
and fibrin. Histologically, injury is most evident at the alveolar epithelial component of
the air-blood barrier - in particular to the alveolar type I (ATI) cells which appear to be
more sensitive to many forms of injury than their counterparts the type II (ATII) cells
(Adamson and Bowden 1974). The second histopathological stage in the natural history
of acute lung injury is much more variable. The 'proliferative' phase is defined by the
onset of epithelial cell regeneration. ATII cells proliferate along alveolar septa from
around day 3 after injury and begin to line the alveolar surface (Tomashefski 2003).
Fibroblasts and myofibroblasts proliferate also, and migrate through breaks in the
alveolar basement membrane into the fibrinous intra-alveolar exudates. During this
period, a proportion of patients will achieve rapid reabsorption of oedema fluid, repair
of the injured air-blood barrier and restoration of lung function. A significant number,
however, will have a very different outcome, with persistence of oedema fluid
organisation of the alveolar debris and intra-alveolar fibrosis. During this third 'fibrotic'
phase, lung architecture is distorted and lung dysfunction worsens.
Constituents of the normal adult lung alveolar epithelium
The epithelium of the 300 million or so alveoli in each adult lung has a total surface
area of approximately 40-80m2 (Weibel and Gomez 1962). This enormous area is
covered exclusively by ATI cells and ATII cells:
Alveolar type I (ATI) cells: cover ~95% of the surface area of the lung with its large
attenuated cytoplasmic processes. The cells are large, (surface area of ~5000/<m2), and
very thin (thickness ~0.2^m) (Weibel 1984; Pinkerton, Gehr et al. 1992) providing the
surface for gas exchange in the lung. ATI and capillary endothelial cells, resting on the
same basement membrane, form the air-blood barrier. Because of its paucity of
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organelles or other obvious internal structure, the ATI cell had been thought of as
having little or no function other than facilitating gas exchange. More recently it has
become clear that these cells are important in regulating alveolar fluid balance (Johnson,
Widdicombe et al. 2002), and transduction of mechanical deformation for control of
surfactant secretion (reviewed in (Williams 2003)).
Alveolar type II (ATII) cells: have a very different role. Described as early as 1977 as
the 'Defender of the alveolus' (Mason and Williams 1977), a concept endorsed and
expanded by Fehrenbach in the light of 24 years of research (Fehrenbach 2001) the
ATII cell covers a fraction of the epithelial surface (<10%) but occurs in roughly equal
numbers to the ATII cell. ATII cells are cuboidal in shape, with an apical surface
covered by microvilli. Flanked by ATI cells they typically occur singly, occupying the
'corners' of alveolar airspaces. Also known as the 'great pneumocyte' or 'granular cell'
('granules' being the phospholipid rich lamellar bodies which are the sine qua non of
the ATII cell) these cells have a plethora of functions (reviewed in (Fehrenbach 2001))
including:
1. Surfactant production and recycling
2. Ion transport
3. Regeneration of damaged epithelium
4. Production of a variety of signalling molecules for integration of inflammatory
and repair processes.
Consequences of alveolar epithelial disruption
Disruption of the alveolar epithelial barrier has several important consequences:
1. Alveolar Flooding: Under normal circumstances, the epithelium is much less
permeable to fluid than the endothelium (Wiener-Kronish, Albertine et al. 1991).
Loss of epithelial integrity removes a significant physical barrier to alveolar
flooding.
2. Impaired Alveolar Fluid Clearance: Loss of epithelial integrity and damage to
ATII and ATI compromises the epithelial fluid transport machinery and impairs
fluid removal from the air-spaces, (reviewed in (Matthay, Folkesson et al.
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2002)).
3. Surfactant Abnormalities: ATII cell injury interrupts the cycle of surfactant
production, secretion and recycling (reviewed in (Baudouin 2004)). This in turn
reduces surfactant production and alters its composition leading to loss of
surface tension reducing phospholipids, alveolar instability and some
compromise of innate immune function. (Haitsma, Papadakos et al. 2004).
4. Invasion of Pathogenic Micro-Organisms: Loss of the physical epithelial
barrier can provide a portal to the circulation for pathogenic micro-organisms.
5. Fibrosis. Disruption of normal epithelial-mesenchymal cross-talk after severe
epithelial injury may facilitate lung fibrosis (Rhodes, Lykke et al. 1989;
Adamson, Hedgecock et al. 1990; Fang 2000; Selman, King et al. 2001).
Alveolar epithelial recovery is key to surviving ALI/ARDS
It is not surprising then that alveolar epithelial recovery is recognised as being crucial to
survival after significant lung injury (Berthiaume, Lesur et al. 1999; Ware and Matthay
2000). Clinical studies have found a correlation between recovery of alveolar epithelial
fluid transport and patient outcomes (Matthay and Wiener-Kronish 1990; Ware and
Matthay 2001). The method used by investigators to assess alveolar epithelial fluid
transport relies on the fact that protein is removed from the alveoli more slowly than
fluid. An estimate of the rate of fluid clearance by the alveolar epithelium can be
obtained by measuring the change in alveolar protein concentration over time: the
magnitude of protein concentration change equates to the rate of liquid clearance
(Berthiaume, Sapijaszko et al. 1991). In human studies, these measurements can be
achieved by aspirating sequential samples of undiluted pulmonary oedema fluid from
the distal airways of intubated patients by passing a suction catheter via the
endotracheal tube (Matthay and Wiener-Kronish 1990).
Most patients with ARDS have impaired alveolar epithelial transport, which is
associated with more prolonged respiratory failure and higher mortality. Ware and
Matthay, divided patients with ARDS into those with maximal fluid clearance (defined
as >14% per hour) and those with impaired clearance <14% per hour). Hospital
mortality was significantly lower in the group whose epithelial fluid clearance was
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maintained (Ware and Matthay 2001).
The ATII cell has a pivotal role in the response to alveolar epithelial injury
Two important aspects of the role of the ATII cell after epithelial injury have been
studied in detail by investigators:
a) Replacement of damaged ATII and ATI cells.
b) Modulation of the fibrotic process in the alveolus.
The replacement of damaged alveolar epithelium
An important function of the ATII cell compartment is in re-epithelialisaton of the
alveolus after injury. One of the first groups to ascribe this role to the ATII was
Adamson et al in 1974. They found that after a hyperoxic insult, ATII cells were
relatively unharmed compared to the ATI population (Adamson and Bowden 1974).
Using thymidine incorporation as a measure of DNA synthesis they found that maximal
epithelial cell proliferation occurred between 3 and 4 days after injury. Induction of
mitotic arrest using colchicine revealed that epithelial cell division was occurring solely
within the ATII cell population, with no dividing ATI cells seen. Sequential study of
epithelial cells labelled with tritiated thymidine after injury showed a reduction of ATII
labelling over time, with a corresponding increase in ATI labelling. No labelled ATII
cells were found in broncho-alveolar lavage (BAL) fluid. This finding provides
compelling circumstantial evidence that the ATII cell population provides a 'reservoir
of dividing cells for the replacement for the injury-susceptible [ATI cell] epithelium'
(Adamson and Bowden 1974).
The role of the ATII cell in epithelial repair - the empirical evidence
The current paradigm for the role of ATII cells in epithelial repair after injury began to
emerge in the early 1970s largely out of the work of two groups - Adamson and in
Winnipeg and Evans in California (Evans, Stephens et al. 1972; Adamson and Bowden
1974; Adamson and Bowden 1975; Evans, Cabral et al. 1975). Adamson's
'Cytodynamic Study in Mice After Exposure to Oxygen' illustrates the methodological
approach (Adamson and Bowden 1974). Using electron microscopy to phenotype
epithelial cells according to specific ultrastructural characteristics Adamson and co-
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workers examined the response of the rat lung to an injury induced by a six-day
exposure to 90% oxygen followed by recovery in room air. By injecting animals with
intravenous tritiated thymidine (3HT) and colchicine 4 hours before death, it was
possible to examine lung alveolar epithelial cell kinetics during recovery. Tritiated
thymidine is a weak beta emitter, and after being incorporated into DNA during the S
phase of cell division the isotope is then detectable by autoradiography, demonstrating
which cells have begun DNA synthesis since labeling. Colchicine inhibits microtubule
polymerization and so prevents formation of the mitotic spindle - arresting cell division
in metaphase and providing a 'snapshot' allowing the identification of cells undergoing
mitosis. The pattern of hyperoxic lung injury was typical with interstitial oedema,
epithelial necrosis and hyaline membrane formation. Alveolar epithelial cell damage
appeared to be limited to the ATI cells, with ATII cells relatively spared. Cell
proliferation after injury was maximal after 2.5 days and by 7 days post oxygen
exposure the lung structure was normal. 3HT labeling was initially confined mostly to
the ATII cell population. The absence of any ATI cells caught in metaphase by
colchicine confirmed the impression that proliferation during recovery was confined to
the ATII cell population. In an extension to this study cells were labeled using a single
pulse of 3HT at 2.5 days post exposure - the point of maximum epithelial proliferation.
The number of silver grains over the nuclei of alveolar epithelial cells was then counted
at daily intervals. Importantly the mean grain count over the nuclei of ATII cells fell to
approximately half, with this decrease beginning 2 days post labelling. Meanwhile the
ATI cells population, which was initially unlabeled, began to acquire nuclear grains in
similar quantities. Analysis of BAL fluid showed that labeled ATII cells were not
disappearing by simply sloughing off into the airspaces. The conclusion drawn by
Adamson from these observations was that the initial process of alveolar epithelial
repair involves multi-focal proliferation of ATII cells. Some of these cells are then
transformed into ATI cells. The finding of a morphologically 'intermediate' population
of epithelial cells, having a 'more flattened than cuboidal' shape, microvilli but no
lamellar bodies provides support for this hypothesis. In a similar fashion Evans and
colleagues used a lung injury model based on nitrogen dioxide (N02) exposure to show
that ATI cell damage was followed by ATII cell proliferation. 3HT labeling,
Autoradiography and electron microscopy showed ATII cell proliferation and transfer
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of 3HT from the ATII to the ATII cell populations apparently via a morphologically
intermediate cell stage (Evans, Cabral et al. 1975). Uhal summarizes the prevailing view
of cell lineage in alveolar epithelial repair at this time as 'the model circa 1980' (Uhal
1997) (figure 1A). Since then there has been significant supplementation of this view,
though the basic structure remains intact (Uhal 1997).
ATII cells as progenitors
The traditional view of stem cell biology is that self-renewing tissues retain a cohort of
tissue-specific 'adult somatic stem cells' which maintain the cell population (reviewed
in (Neuringer and Randell 2004)). In the adult lung, the epithelial cell proliferation rate
is normally very low, but increases dramatically in response to injury (reviewed in
(Uhal 1997)). This conditional nature of lung cell proliferation (i.e. proliferation in
response to stimulus) sets it apart from better understood systems with continuous
turnover e.g. skin, gut and haematopoietic system (Marshman, Booth et al. 2002;
Alonso and Fuchs 2003; Kondo, Wagers et al. 2003). Current thinking derived from
examination of these other tissues is that stem cells inhabit specific microenvironments
(niches) that provide cues that modulate cell fate (Watt and Hogan 2000). Broadly,
unicellular organisms and invertebrates tend to use 'invariant' mechanisms to generate
stem cell progeny. Here, each stem cell division is asymmetric and predictable, giving
rise to one stem cell daughter, and a further daughter which goes on to differentiate
(Morrison, Shah et al. 1997). In contrast to this it is thought that the dividing strategy
used by stem cells in most mammalian self-renewing tissues is one of 'populational
asymmetry' (reviewed in (Watt and Hogan 2000)). Here a stem cell gives rise to two
daughter cells, which can be either stem cells or committed 'progenitors', destined for
differentiation. This mechanism allows a degree of flexibility in the progeny produced,
allowing response to environmental factors at a population level. It is likely that to
conserve stem cells they cycle infrequently and the majority of cell replacement is
accomplished through the division of committed progenitors: the so-called 'transiently
amplifying compartment' (Neuringer and Randell 2004). The prevailing view is that the
ATII cell is the alveolar epithelial progenitor cell.
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Extra-alveolar stem cells
It is possible that after severe injury to the alveolar epithelium, repair mechanisms may
involve progenitor cells originating from outside the alveolus. Examination of the distal
airway epithelium of the mouse 28 days after bleomycin injury revealed a
subpopulation of epithelial cells containing Clara cell-specific protein (CC10) mRNA,
present in alveolar-like structures (Daly, Baecher-Allan et al. 1998). The inference
drawn by Daly et al. from this finding was that alveolar epithelial progenitors could
arise from the bronchiolar epithelium.
More controversially, recent work challenges the dogma that tissues are maintained
solely by organ-specific stem cells. There is evidence that adult stem cells from the
bone marrow are able to regenerate a variety of cell types, including the alveolar
epithelium (Kotton, Ma et al. 2001; Grove, Lutzko et al. 2002; Theise, Henegariu et al.
2002; Kleeberger, Versmold et al. 2003). In experimental models, injury appears to
increase incidence of engraftment of donor bone marrow cells into the lung e.g. (Ortiz,
Gambelli et al. 2003; Hashimoto, Jin et al. 2004). It is still unclear how these cells take
on alveolar epithelial phenotypes, and whether or not they must transit through an
'intermediate' stage. Some of the appearances of cells containing both non-lung and
lung cell markers after injury can be explained by cell fusion (Spees, Olson et al. 2003).
Alternatively, marrow cells may actually change tissue type. Despite the above findings,
the actual significance of circulating cells in the process of lung epithelial repair after
injury remains controversial and unanswered.
ATII cells and lung fibrosis
The original hypothesis of the pathogenesis of pulmonary fibrosis postulated an initial
injury to the lung led to chronic inflammation, this in turn inducing fibrogenesis and
later scar formation. More recent observations, however, provide evidence that this
scheme is not central to the pathogenesis of interstitial lung disease and puts alveolar
epithelial repair firmly at the centre of the interplay of factors leading to conditions such
as idiopathic pulmonary fibrosis (IPF), or end-stage ARDS (reviewed in (Geiser 2003)).
Recognition of the fact that fibrotic foci are much more prominent than evidence of
inflammation in lung tissue during fibrosis (Kuhn, Boldt et al. 1989), and the lack of
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efficacy of anti-inflammatory interventions in the treatment of IPF or ARDS (2000),
(Adhikari, Burns et al. 2004) has led to a focus on the fibrotic pathway itself (Selman,
King et al. 2001). Increasing evidence suggests that fibrosis results from alveolar
epithelial injury, with subsequent abnormal wound repair characterised by alterations in
mesenchymal-epithelial interactions at the level of the alveolus (Selman, King et al.
2001; Gauldie, Kolb et al. 2002; Selman and Pardo 2002). After injury, efficient
alveolar epithelial repair can inhibit the development of pulmonary fibrosis (Adamson,
Hedgecock et al. 1990). The ability of an intact alveolar epithelium to suppress fibrosis
has been demonstrated in animal models (Adamson, Young et al. 1988), with delayed
alveolar re-epithelialisation seeming to facilitate fibrosis. Attempting to facilitate
restoration of epithelial integrity by blocking ATII-cell apoptosis results in reduced
fibrosis after bleomycin injury in rats (Wang, Ibarra-Sunga et al. 2000) and mice
(Kuwano 2001). Actively promoting ATII proliferation with Keratinocyte Growth
Factor (KGF), also known as Fibroblast Growth Factor-7 (FGF-7), can protect the lung
if given prior to a variety of injurious agents including bleomycin or oxygen (Guo, Yi et
al. 1998), radiation (Takeoka, Ward et al. 1997), alpha-naphthylthiourea (Mason, Guery
et al. 1996) and Pseudomonas pneumonia (Viget, Guery et al. 2000). Similarly another
ATII cell mitogen Hepatocyte Growth Factor (HGF) can reduce injury caused by
intratracheal hydrochloric acid if given post exposure (Ohmichi, Matsumoto et al.
1996).
Epithelial and mesenchymal cells signal each other 'bidirectionally and dynamically'
(Fang 2000). On a molecular level, the interactions between epithelium and
mesenchyme have yet to be worked out, but appear to occur in two main ways. Firstly
there is release of soluble mediators in a paracrine fashion. Epithelial cells release TGF-
beta and platelet derived growth factor (PDGF), which modulate fibroblast proliferation
and matrix deposition. Conversely, fibroblasts influence epithelial cell function by
releasing epidermal growth factor (EGF), KGF and HGF among other things. A second
means of communication occurs via direct intercellular contact in an anatomical region
conceptually termed 'the attenuated fibroblast sheath' (Evans, Van Winkle et al. 1999).
The epithelium and mesenchyme communicating in this way form a notional 'epithelial -
mesenchymal trophic unit' within which it is thought that ATII cells exert a restraining
influence on fibroblast proliferation, this may be lost when epithelial injury interferes
Page 23
with this relationship (Fang 2000). Anatomical evidence in support of the notion of
close epithelial-mesenchymal contact in human lungs comes from examination of
uninjured lung tissue by scanning electron microscopy. It appears that fibroblasts
maintain physical communication between ATI/ATII cells and the mesenchyme by
spanning apertures visible in the basal lamina of the epithelium (Sirianni, Chu et al.
2003).
It seems clear that successful repair of the alveolus after injury requires timely re-
epithelialisation and restoration of the epithelial component of this integrated system
allowing normalisation of epithelium-mesenchymal communications. Failure of
alveolar repair and unchecked signalling between compartments leads to excessive
matrix deposition, intra-alveolar fibrosis and progressive lung disease (Adamson,
Hedgecock et al. 1990; Fang 2000; Selman, King et al. 2001; Sheppard 2001)
Does alveolar epithelial regeneration recapitulate ontogeny?
Parallels in the genetic control of development and repair: Lung development and
repair are controlled by complex stimulatory and inhibitory signalling mechanisms
(Warburton, Schwarz et al. 2000). Analysis of the genetic machinery central to
governing early lung morphogenesis reveals a high degree of stereotypy suggesting a
degree of genetic 'hard wiring' (Warburton and Bellusci 2004). Pattern formation in the
airways is not well understood, but it is likely that the raw material for the process of
branching morphogenesis (BM) arises out of the physical properties of a 2D epithelial
cell sheet 'fingering' as it penetrates the mesenchyme (Fleury and Watanabe 2004). A
layer of order and control is superimposed by tempero-spatial patterns of gene
expression (Warburton and Bellusci 2004). Significant parallels have been drawn
between the genetic mechanisms governing BM in flies, mice and humans (Metzger and
Krasnow 1999; Beitel and Krasnow 2000). FGF receptor tyrosine kinase signalling is
required for the initiation and maintenance of tracheal branching in the fly, and also
crucial to all stages of lung morphogenesis in the mouse. FgflO null mutants have no
bronchial modelling distal to the carina (Min, Danilenko et al. 1998; Sekine, Ohuchi et
al. 1999), whereas double null mutation of Fgfr3 and Fgfr4 abrogates postnatal alveolar
morphogenesis (Weinstein, Xu et al. 1998). Similar studies on the sprouty family, are
cited as further evidence of functional conservation of key regulatory elements across
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phyla during development (Warburton and Bellusci 2004).
In adult ATII cells survival, migration and proliferation during remodelling after
hyperoxic injury is stimulated by culture on fibronectin, and exposure to Epidermal
Growth Factor (EGF) (Buckley, Driscoll et al. 2001). The highly conserved nature of
the mechanisms controlling lung development, and the involvement of some of these
signals in the repair of adult lungs have been cited as evidence that the same processes
are involved in development and repair (Warburton and Bellusci 2004).
'Intermediate' cells are identified in alveolar development and repair: Cells which
have a morphology combining ATII and ATI cell features have been reported after a
variety of injuries to the alveolar epithelium (Adamson and Bowden 1974; Evans,
Cabral et al. 1975; Takahashi, Aida et al. 1994), and are visible after KGF induced
hyperplasia (Fehrenbach, Kasper et al. 1999). The proposition that the appearance of
these cells represents the activation of a developmental process during repair is
supported by descriptions of similar cells observed during alveolar development.
Flecknoe et al. have performed a series of studies examining the development of the
alveolar epithelium (Flecknoe, Harding et al. 2000; Flecknoe, Wallace et al. 2002;
Flecknoe, Wallace et al. 2003; Flecknoe, Boland et al. 2004). Their experimental
paradigm involves the alteration of basal lung expansion in the foetal sheep - increasing
expansion by tracheal occlusion (TO) or decreasing expansion by lung liquid drainage
(LED) - for a period of several days. Composition of the alveolar epithelium was then
surveyed by electron microscopic examination of epithelial cell morphology in random
tissue sections, with corroborating information on numbers of functional ATII-cells
from the quantification of surfactant protein mRNA. The group have assigned four
distinct cell morphologies: 1. 'Alveolar epithelial stem cells', having cuboidal shape and
containing abundant cytoplasmic glycogen deposits. 2. 'Type I alveolar epithelial cells'
with long flattened cytoplasmic extensions, flattened elongated nuclei and little
perinuclear cytoplasm. 3. 'Type II alveolar epithelial cells' were rounded with apical
microvilli and lamellar bodies. 4. 'Intermediate cells' displayed both ATI and ATII
features, but were a heterogeneous group. To qualify, cells were required to have a
flattened nucleus and elongated cytoplasm, but also lamellar bodies and usually apical
microvilli (Flecknoe, Harding et al. 2000).
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The group found that control foetal lungs (113-120/147 days gestation) contained
around 29% ATII, 65% ATI and 6% morphologically intermediate cells (Flecknoe,
Harding et al. 2000). These proportions could be manipulated by altering basal lung
expansion and/or glucocorticoid infusion. Tracheal occlusion produced a decrease in
ATII cell numbers to 9% after 2 days with a corresponding increase in 'intermediate'
cells to 24%. There was no change in ATI cell number at this early time point, but after
10 days of TO ATI cells made up 90% of the alveolar epithelial population with
intermediate cell number back down to control levels (Flecknoe, Harding et al. 2000).
The group inferred that an increase in basal lung expansion by tracheal occlusion had
caused ATII cells to differentiate into ATI cells via an 'intermediate' stage. Further
work using this model yielded empirical evidence to suggest that this change in the
proportion of ATII and ATI cells following TO is reversible if the foetus is then
subjected to lung liquid drainage to chronically reduce basal lung expansion (Flecknoe,
Wallace et al. 2002). A comparison of the contributions of reduced lung expansion, and
Cortisol infusion to the increase in ATII-cell numbers showed that each had an additive
effect, but probably exercised through different mechanisms (Flecknoe, Boland et al.
2004).
While this approach to identifying cell type using ultrastructural markers has been
widely used, and still remains the gold standard for individual cell phenotyping, it has
significant limitations. It is usually only practicable to survey a very small area of lung
by electron microscopy. Even with careful attention to sampling technique in order to
try and obtain representative images, it is difficult to place the very high magnification
phenotyping-information-rich images from the electron microscope into the context of
the tissue or organ under examination without losing access to morphological markers
of cell-type.
Williams and Dobbs (Williams and Dobbs 1990) used an immunotargeting approach to
lung epithelial cell phenotyping, avoiding some of the limitations inherent in a solely
morphology based approach. Using immunofluorescence and immunoblotting to detect
ATI and ATII cells specific markers during development they found that RTI40, a ATI
cell specific marker, first appeared on the apical surfaces of lung cells at day 15 (by
immunofluorescence, but was not present in concentrations detectable by immunoblot
until day 17). Macula pomifera agglutinin (MPA), a ATII-cell marker, was first
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observed on day 16. By day 20, staining with both markers was widespread throughout
the alveolar epithelium, and a population of cells was detected which appeared to
express both markers simultaneously. The authors were unable to stain the same lung
section with both markers at the same time and instead stained 'serial frozen sections' to
detect colocalisation of markers. Because the thickness of sections (4-6/rm) was less
than the diameter of the epithelial cells under examination it was suggested that staining
visible in two consecutive sections arising from the same place on the slide was likely to
originate from the same cell.
Immunotargeting as a means of studying cell types
Adamson and Bowden in their seminal paper allude to the difficulty involved in
studying the behaviour of the alveolar epithelium because of "...the problems of
combining adequate numerical analysis with precise cellular identification." (Adamson
and Bowden 1974). 'Immunotargeting' is a term used by Funkhouser to describe the use
of antibodies to antigens specific to a particular cell lineage or stage of differentiation to
isolate cell subpopulations of interest (Funkhouser and Peterson 1989). Used in this
way, immunofluorescence is a powerful tool for characterising cell populations and
analysing their interactions. I used a panel of ATI and ATII cell specific antibodies to
investigate the alveolar epithelium in control lungs, after lung injury, during lung
development and in primary cell culture.
The panel of antibodies used
Classification of proteins: McElroy and Kasper have differentiated between marker
proteins expressed by ATI cells, by grouping them according to cell specificity
(McElroy 2004). Cell-specific proteins are expressed by the target epithelial cell (in this
case ATI-cells) in the lung and nowhere else. Cell-selective proteins are expressed by
the target cells, and other lung cells but not other cells in the same tissue compartment
(in this case the alveolar epithelium). Cell associated proteins are expressed more
abundantly by target cells than other cells in the same tissue compartment. In this study
I have used antibodies against the following panel of cell-specific and cell-selective
proteins:
Aminopeptidase N, p!46, MMC4 antigen: Aminopeptidase N was first located on the
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apical membranes of ATII cells in the rat lung during a search for rat lung epithelial cell
specific proteins using monoclonal antibodies (Funkhouser, Cheshire et al. 1987). The
membrane glycoprotein was initially labelled pi46, though subsequent isolation and
partial sequencing revealed that it was identical to aminopeptidase N (Funkhouser,
Tangada et al. 1991). Similarly Boylan et al. raised a monoclonal antibody, MMC4,
specific to rat ATII cells and Clara cells in the distal airways (Boylan, Pryde et al.
2001). Later identification of the MMC4 antigen by immunoprecipitation and mass
spectrometry has shown it to recognise aminopeptidase-N (Franklin 2004). Speculating
on the probable functions of aminopeptidase-N in the lung by analogy with its role in
other contexts, Funkhouser et al suggest that these may include regulation of autocrine
and paracrine signals, post translational modification of proteins (e.g. surfactant
associated proteins) and possibly activation of antibacterial peptides (Funkhouser,
Tangada et al. 1991).
Rat type II cell 70-kDa protein (RTII70): Anti-RTII70 is a monoclonal antibody,
specific to the apical surface of rat ATII cells. The function of the RTII70 protein antigen
is not known (Dobbs, Pian et al. 1997).
Pro-Surfactant Protein C (Pro-SP-C): Surfactant protein C (SP-C) is produced from
proteolytic cleavage of a larger precursor; pro-SP-C. Beers et al. have produced an anti-
pro-SP-C polyclonal antibody, and demonstrated that pro-SP-C is unique to the
intracellular compartment of ATII cells in the lung (Beers, Wali et al. 1992; Beers, Kim
et al. 1994).
Surfactant protein D (SP-D): Surfactant protein D (SP-D) is a product of ATII cells
involved in the opsonisation of inhaled pathogens and allergens. Lung inflammation
significantly increases the quantity of SP-D in BAL fluid (Haczku, Atochina et al.
2001). Cao et al. have produced a rabbit polyclonal antibody using peptides from the N-
and C-terminal regions of human SP-D. This antibody recognises rat, murine and
human SP-D (Cao, Tao et al. 2004).
Rat type I cell 40-kDa protein (RTI40), Type I cell alpha protein (TI-a): This is an
apical membrane protein that is specific to ATI cells in the lung. The protein was
discovered by Dobbs et al. as part of an effort to produce antibodies with which to
characterise ATI cells (Dobbs, Williams et al. 1988). RTI^ protein is also detected
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outside the rat lung in the choroid plexus and ciliary epithelium (Williams, Cao et al.
1996). A monoclonal antibody against RTI^ has enabled identification of the rat gene,
and revealing homology with proteins expressed by a number of other cell types
including an osteoblast cell line, rat kidney podocytes, mouse thymus, a mouse
osteoblast cell line and mouse keratinocytes (reviewed in (McElroy 2004)). The role of
RTI^ in the lung is unknown, but mice with targeted mutations at the RTI40 locus die at
birth with respiratory failure (Ramirez, Millien et al. 2003; Schacht, Ramirez et al.
2003). It is speculated that the protein may be important in initiating and maintaining
the extended and flattened ATI phenotype (Williams 2003; McElroy 2004).
Table 4. ATI and ATII cell-specific or selective proteins
Name (reference) Cell specificity in the rat lung Antibody isotype
MMC4 ATII & Clara IgG2a
(Boylan, Pryde et al. 2001)
Anti-RTII70 ATII IgG3
(Dobbs, Pian et al. 1997)
Anti-Pro-SP-C ATII Rabbit polyclonal
(Beers, Wali et al. 1992)
Anti-RTI40 ATI IgGl
(Dobbs, Williams et al. 1988)
Anti-SP-D ATII & Clara Rabbit polyclonal
(Cao, Tao et al. 2004)
Laser Scanning Confocal Microscopy
The concept of the confocal microscope was first invented by Marvin Minsky (patented
in 1957) to visualise neurons. The key feature of the confocal microscope is the 'spatial
confinement' of detected light (signal) that reduces image blurring caused by light
scatter. This is done by imaging one 'point' at a time.
A confocal imaging system achieves rejection of out-of-focus signal by two strategies:
a) Illumination of a single point of the specimen at any one time with a focused
beam, so that illumination intensity drops off rapidly above and below the plane
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of focus.
b) Use of a pinhole aperture so that light emitted away from the point in the
specimen being illuminated is blocked from reaching the detector.
Figure (figure 2A) shows a simplified diagram of the optics of a confocal microscopy
system, and illustrates how emitted light from above or below the optical plane of
interest is screened from the detection device by a detector pinhole, (figure 2B) Shows
a schematic of the implementation of this type of system, as used in the present study.
In general, a confocal microscope that is set up correctly will always give a better image
than can be obtained with a standard epifluorescence system because of its rejection of
out-of-focus interference. The improvement can vary between marginal, in the case of
very flat specimens, to spectacular in the case of large, whole-mount specimens. In fact,
it can be almost impossible to gain useful information from a large, microscopically
thick specimen with conventional microscopy, yet obtain clear optical sections with the
confocal microscope (figure 3). Use of a confocal system will also increase the
effective image resolution achievable, and improve signal to noise ratio. By allowing
the imaging of multiple single thin optical sections at different focal planes through a
thick specimen ('z-stack'), confocal microscopy also provides the ability to image in
three dimensions.
Combining Immunotargeting and LSCM in lung cell research
Use of LSCM technology has become an increasingly popular tool in imaging
biological systems since the 1980's. LSCM has often been used simply to obtain a
clearer version of the image that would have been obtainable using epifluoresence,
ignoring the other possibilities opened up by this technology. The lung in particular,
with its complex three dimensional structure and intricate distal airspaces lends itself to
LSCM imaging. In this project I have combined modern LSCM technology and image
analysis tools with immunotargeting using novel antibody combinations to achieve the
following:
a) Cell phenotyping: Electron microscopy has been the tool of choice for
phenotyping lung cells using morphological markers (Evans, Stephens et al.
1972; Adamson and Bowden 1974; Adamson and Bowden 1975; Evans, Cabral
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et al. 1975) and remains so for many investigators (Flecknoe, Wallace et al.
2003; Flecknoe, Boland et al. 2004). This approach requires the identification of
cell type based solely on morphology, which does not distinguish between
morphologically similar cells that are destined for different pathways of
differentiation during development or repair.
b) Immunotargeting with colocalisation: Phenotyping by immunofluorescence
often demands accurate assessment of colocalisation of antibody staining on a
single cell. An important requirement for this is the ability to image at a high
enough resolution to avoid the confounding influence of 'pseudo-colocalisation'
i.e. where two discrete and differently labelled objects are adjacent, but too
small to be individually resolved by the imaging system used and appear as a
single dual stained entity. LSCM, with deconvolution of images (see below) is a
much more powerful technique than standard epifluorescence to accomplish
this.
c) Examination of 3D structure of airspaces: Volume rendering of image stacks
after immunotargeting allows examination of antigen distribution, cell
phenotypes, and cell-cell relationships in three dimensions.
d) Quantification: A survey of the cells in a tissue section or cell culture is
difficult using morphology based electron microscopic criteria for phenotyping.
The demands of tissue preparation for electron microscopy are such that only a
very small amount of tissue can be visualised at a time. Immunotargeting
combined with LSCM provides a powerful phenotyping tool while allowing
large areas of tissue (even sections of entire organs) or cell culture to be
surveyed contiguously.
Experimental model of alveolar epithelial injury
To carry out our investigation I sought to use a clinically relevant model of lung injury.
As indicated earlier the commonest clinical disorders associated with ALI/ARDS can be
broadly grouped according to their mechanism of injury to the lung. This distinction has
been postulated for some time and was recognised by the American-European
Consensus Conference Committee on ARDS in 1994 (table 1). Disorders resulting in a
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'direct' injury to the alveolar air-blood barrier (most commonly gastric aspiration and
pulmonary infection) appeared to inflict damage to the alveolar-capillary membrane via
an intense inflammatory infiltrate producing oxidants and proteases. Conversely
'indirect' injury to the lung (caused most often by sepsis syndrome, severe non-thoracic
trauma or massive blood transfusion) was thought to be predominantly the result of
circulating chemokines, cytokines and other mediators generated initially by extra¬
pulmonary sources of inflammation. This largely speculative distinction was given
weight by the clinical observations of Gattinoni et al. who reported differences in
respiratory mechanics and response to positive end-expiratory pressure in what they
described as 'pulmonary ARDS' (ARDSp) compared to patients with 'extra-pulmonary
ARDS' (ARDSexp) (Gattinoni, Pelosi et al. 1998). Further observations confirm the
likely existence of two distinct pathogenic pathways for ARDS having different
morphological aspects, respiratory mechanics and response to ventilatory strategies
(Pelosi, D'Onofrio et al. 2003), though it is not clear how these differences affect
clinical outcomes. The main difference in histology and biochemistry in ARDSp
compared to ARDSexp are summarised in table 5.
Table 5: Histological and biochemical alterations in pulmonary and
extrapulmonary acute respiratory distress syndrome,













































I chose initially to use a rat model of unilateral pneumonia. This was primarily designed
to cause a sub-lethal 'direct' lung injury, primarily affecting the alveolar epithelium,
allowing examination of subsequent epithelial repair. Inoculation of the animals with
Staphylococcus aureus strain 8325-4, or Streptococcus pneumoniae strain D39 was
performed via the oral route to avoid animal injury and facilitate uncomplicated
recovery (figure 4A-D). The efficacy of this method of unilateral inoculation has been
confirmed by Bakker-Woudenberg, who instilled X-ray contrast medium using the same
technique, then followed with X-ray examination (figure 4F) (Bakker-Woudenberg
2003). Advantages of this approach include a reproducible infectious disease model,
with low variation between individuals (Bakker-Woudenberg 2003). S. aureus 8325-4
has been shown previously to cause an acute injury to the air-blood barrier in the lung at
the inoculating dose we used. McElroy et al. found histological evidence of
inflammation, and increased leukocytes and protein in the BAL fluid at 4 hours post
instillation (McElroy, Harty et al. 1999).
We also investigated the use of an 'indirect' model of injury secondary to haemorrhage.
The haemorrhage model offered the possibility of a more finely controlled and
homogeneous lung injury, which could be combined with positive pressure ventilation
of the anaesthetised animal in order to provide an approximation to the clinical scenario
in the intensive care unit. We used a system similar to that used by Modelska et al.
which has been shown to cause endothelial injury and alterations in alveolar epithelial
barrier function (Modelska, Matthay et al. 1997). Our initial work involved detection of
any injury to the alveolar epithelium sustained during a brief period of haemorrhage,
resuscitation and mechanical ventilation. These initial observations were intended to
provide a platform for further work.
Aims of this thesis
(a) Development of a robust and informative method of 'immunotargeting' the lung
alveolar epithelium using a combination of antibodies to cytotypic (cell-specific)
antigens, including qualitative and quantitative analysis of the lung alveolar
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epithelium using laser scanning confocal microscopy and subsequent image
analysis.
(b) Set up of a system for the isolation and culture of rat lung epithelial type II cells.
(c) To define the phenotype of lung alveolar epithelial cells using a novel
combination of cell-specific antibodies.
(d) To examine the phenotype of the alveolar epithelium during repair in a model
of S. aureus pneumonia, and in S. pneumoniae pneumonia using the same panel
of antibodies.
(e) To examine the rat lung epithelium during development and ATII cells in
culture to look for immunotypic features common to:
• alveolar epithelial cells during repair in the in vivo pneumonia model
• during alveolar expansion in lung development
• cell phenotype changes over time in the in vitro cell culture system.
(f) To examine the extent of injury to the alveolar epithelium of the rat after
haemorrhage and resuscitation, with a view to developing a model of 'indirect'
lung injury.
Hypotheses:
(a) After Staphylococcus aureus injury, the repairing alveolar epithelium
contains 'intermediate' cells with a unique 'differentiation' phenotype.
(b) The process of epithelial regeneration after Staphylococcus aureus injury is
generic, and evidence of the same process should be detectable in other in




All reagents were obtained from Sigma-Aldridge Ltd (Poole, Dorset, UK) unless
otherwise indicated. Anaesthetics and other veterinary pharmaceuticals were supplied
by Genusxpress Ltd, Aberdeen UK. A list of the composition of stock solutions is given
in Appendix A. Animal work was carried out in accordance with the Animals Scientific
Procedures Act 1986.
Alveolar epithelial type II cell isolation and culture system
The cell isolation procedure used was modified from that of Dobbs et al. (Dobbs,
Geppert et al. 1980).
1. Dulbecco's Modified Eagle's Medium (DMEM), and Phosphate Buffered Saline
(PBS) solutions were warmed to 37°C.
2. Adult male Sprague-Dawley rats (specific-pathogen-free. Harlan, UK) weighing
150-200g were terminally anaesthetized using a mixture of heparin sulphate 500
units and pentobarbital 0.5mls.
3. The descending aorta was cut and the animal exsanguinated. A small cannula
was inserted into the trachea. The lungs were perfused with approximately
20mls of warmed 'with'-Ca/Mg buffer solution (see Appendix A) via the right
ventricle/pulmonary artery using a 26G needle and 20mls syringe. A nick was
made in the left atrium using a pair of fine scissors to allow escape of perfusate.
The lungs were ventilated with air during the perfusion using a 10ml syringe
attached to the tracheal cannula. Perfusion and ventilation were continued until
the lungs were white in colour.
4. The lungs were placed in warmed isotonic saline until ready, then lavaged 8
times using 'without'-Ca/Mg buffer.
5. Elastase solution 12.5% (wt/vol) was freshly prepared by dissolving 5mg of
elastase (porcine pancreas, specific activity of powder 105 units/mg at 25°C,
Roche Ltd, UK) in 40mIs of 'with'-Ca/Mg buffer per rat.
6. Lungs were lavaged a further 2 times using 'with' Ca/Mg buffer. Lungs were
lavaged once with elastase solution. Elastase solution was then used to inflate
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the lungs to total lung capacity (TLC). The lungs were then suspended in beaker
of water, in a water bath at 39°C. A plastic 2.5 mis syringe was used as a funnel,
and attached to the tracheal catheter to allow periodic addition of elastase
solution to maintain inflation. Total elastase inflation time was 25 minutes
7. DNAase solution was freshly prepared using 2mg DNAase (DNase I Bovine
Pancreas, Grade II. Roche Diagnostics, Mannheim Germany) per rat diluted in
2mls of 'with' Ca/Mg buffer. Lobes of the digested lungs were dissected free of
other remaining non-lung tissue and added to DNAase solution before chopping
finely (~5mm cubes). 4mls of Foetal Calf Serum (FCS) was added to the lung
tissue, topped up to 40mls using 'with' Ca/Mg buffer and hand shaken for 3
minutes.
8. The crude tissue suspension was passed through progressively finer filters: 2
layer gauze, 4 layer gauze. 150/rm, 15/^m and Ipim mesh. The cell suspension
was then centrifuged at llOOrpm for 6 minutes then resuspended in 20mls of
warmed DMEM.
9. IgG coated plates were washed 5 times with PBS before use. lOmls of cell
suspension was then plated onto each IgG coated plate and incubated at 37°C for
20-30mins. Plates were then removed from the incubator and the supernatant
containing non-adherent ATII cells retrieved. The IgG plates were washed with
a further 5mls DMEM which was added to the ATII cell supernatant.
10. The cell suspension was spun down at llOOrpm for 6 minutes and cells
resuspended in culture medium (see Appendix A). Cells were counted then spun
down and resuspended as appropriate to obtain the desired concentration for
plating.
Cell Plating: Correct plating density was achieved by counting the final cell suspension
using a haemocytometer and diluting to the required concentration. Cells were plated on
circular coverslips, pre-coated with fibronectin (1:50 solution of fibronectin allowed to
stand on the coverslips overnight at 4°C, and excess liquid removed before plating) and
placed at the bottom of the wells in a 24-well plate.
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Modified Papanicolau staining for assessment of purity.
This standard technique for assessing the purity of freshly isolated ATII cells is based
on the method described by Dobbs (Dobbs 1990).
1. Cell in a suspension of 2xl05 cells per ml were cytospun onto slides at 300rpm
for 3 minutes and left to air-dry overnight.
2. Slides were first dipped in hematoxylin (Harris' Formulation) for 3 minutes,
then rinsed in distilled water.
3. Dipped for 2 min in lithium carbonate solution, (i.e. 2mls of saturated lithium
carbonate solution in 158mls of water. Saturated solution made by dissolving of
256mg lithium carbonate in 20mls of DDW) then rinsed by dipping slides in
double-distilled water for 5 sec.
4. Dipped in 50% ethanol for 90 sec, 80% ethanol for 15 sec, 95% ethanol for 15
sec, 100% ethanol for 30 sec.
5. Dipped in xylene:ethanol 1:1 for 30 sec
6. Dipped in xylene for 1 min
7. Mounted using a cover-slip.
Rat pneumonia models: Staphylococcus aureus and Streptococcus pneumoniae.
The rat pneumonia model by direct instillation of bacteria into the lower airways was
based on the technique previously described by Bakker-Woudenberg et al. (Bakker-
Woudenberg, de Jong-Hoenderop et al. 1979). Instillate preparation, animal inoculation
and tissue harvesting were performed by Christine Tyrrell. The Staphylococcus aureus
strain used in this study was 8325-4, and was provided by Dr Tim Foster, Department
of Microbiology, Moyne Institute of Preventive Medicine, Trinity College, Dublin,
Ireland. The Streptococcus pneumoniae used was serotype 2 strain D39, NCTC 7466
and was obtained from Dr Tim Mitchell, Division of Infection and Immunity,
University of Glasgow, UK.
1. Bacteria were plated out from glycerol stocks onto Blood Agar Base (BAB)
plates (Tryptic soy agar plates + 5% sheep's blood, BD Biosciences, Oxford,
UK). Bacterial stocks were kept on dry ice to minimise freeze/thawing. A
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scraping of glycerol stock was spread onto the BAB plate using an inoculation
loop in a sterile Class II cabinet. Plates were incubated at 37°C overnight.
2. Overnight cultures were started in Todd Hewitt (TH) Broth (BD Biosciences,
Oxford, UK), from a single colony. 3mls of TH Broth was inoculated with a
single bacterial colony using inoculation loop. The broth was then incubated
overnight at 37°C (approx 18 hrs). (S. aureus containing broth was shaken at
approximately 220rpm. while incubating, S. pneumoniae broth was not shaken
as this had an adverse effect on subsequent bacterial growth).
3. Making up bacterial instillate: Bacterial broths were kept on ice and agitated
periodically to ensure bacteria remained in suspension. The optical density
(O.D.) of overnight cultures was measure using spectrophotometer (600nm
wavelength) to estimate bacterial concentration. The required quantity of
bacterial suspension was aliquotted into a sterile container. Cells were washed
twice with sterile endotoxin free PBS (with Mg/Ca), centrifuging for 3 minutes
at approx 13,000 rpm and resuspending between spins. The bacterial pellet was
finally resuspended in 1.5mls sterile PBS and kept on ice.
4. Anaesthetising rats: Rats (specific-pathogen-free Sprague-Dawley males, 300-
350g, Harlan, UK) were anaesthetised with an intraperitoneal injection of
Fentanyl citrate 0.315 mg/ml (1 mg/kg/i.p.) and Fluanisone lOmg/ml (33
mg/kg/i.p.) mixed with Midazolam hydrochloride 5mg/ml (17 mg/kg/i.p.).
5. Instillation: Rats were maintained in a vertical position by suspension on a
horizontal wire by the front upper incisors (figure 4A). An intubation wedge (in
the form of a modified 2ml Eppendorf tube, Fisher Scientific, Leicester, UK)
was placed in the mouth and a tracheal catheter (0.96 external diameter, Portex
Fine Bore Polythene Tubing, Portex Ltd, Kent UK) inserted. 0.5ml bacterial
suspension (or PBS control) was instilled into the lungs via the tracheal catheter
using a 1ml syringe, (figure 4B-E). A further blast of air was blown into the
lungs to aid instillation. A successful tracheal instillation resulted in a transiently
increased respiratory rate.
6. Recovery: Rats were given an intraperitoneal injection of 3 mis warmed sterile
saline and recovered in cage with heating pad, inside a Class II cabinet (animals
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were removed from the cabinet after 24 hours).
7. Determination of concentration of organisms: Bacterial suspension was
plated onto BAB plates to determine concentration or organisms expressed as
the number of colony forming units (cfu). 50/d of bacterial suspension at 10"3
dilution was plated onto half of a BAB plate, and an erythromycin antibiotic disc
placed on the inoculated half of the plate, to confirm sensitivity. 50/d of a 10"6
dilution of bacteria was plated onto the other half of the plate, spreading with
inoculation loop. The plate was incubated overnight at 37°C.
Harvesting, fixation and frozen sectioning of control and instilled adult rat
lungs for immunohistochemistry and electron microscopy
1. At the appropriate time point post inoculation, rat lung perfusion was performed
in a similar way to the ATII cell isolation technique. After the lungs had been
perfused with saline and were blanched, they were inflated with 4%
paraformaldehyde in PBS (wt/vol) solution through the tracheal cannula. Care
was taken to avoid causing a leak by over inflating. The tracheal cannula was
clamped using haemostat to maintain inflation and the lungs submerged in a
beaker containing 4% paraformaldehyde.
2. After ~30 minutes, tissue was cut into slices using razor blade and re-submerged
in 4% paraformaldehyde for further 1-2 hours.
3. Tissue Selection: The left upper lobe was used consistently for in control
animals. When harvesting lungs from the pneumonia model the
inflamed/consolidated area of lung was identified macroscopically as paler than
the rest of the tissue. This was removed and cut into 5mm cubes for sectioning.
A non-inflamed area of the same lung was also removed and treated in the same
way. Tissue cubes were processed either for frozen sectioning and
immunohistochemistry of preparation for electron microscopy:
Preparation of lung tissue for immunohistochemistry:
1. Tissue was left in 30% sucrose solution at 4°C overnight for cryoprotection. The
following day blocks of tissue were submerged in Optimal Cutting Temperature
Compound (OCT) and frozen in Freon 22 initially then plunged into liquid
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nitrogen. ~3/<m sections were cut using a Bright cryostat (Huntington, UK).
2. Tissue sections were stored at -70°C until used.
Preparation of lung tissue for electron microscopy:
1. Lung tissue was first cut into 1mm cubes, then fixed in 3% glutaraldehyde in
sodium cacodylate buffer for 4 hours (minimum) to overnight (maximum) at
4°C.
2. After washing in 0.1 M sodium cacodylate buffer tissue was fixed in 1% osmium
tetroxide in sodium cacodylate buffer for 2 hours at 4°C.
3. Tissue was dehydrated through a series of grades of ethanol (15 minute changes
at lower grades, 3x30 minute changes at 100% ethanol), washed in propylene
oxide (2 changes at 20 mins each change) and impregnated with Araldite epoxy
resin for 2-3 hours.
4. After embedding in fresh Araldite epoxy resin 50 nanometer sections were cut
on a LKB Nove ultramicrotome and placed onto 300 mesh copper grids. Grids
were stained with uranyl acetate and lead citrate.
5. Grids were viewed on a Jeol 100CXII electron microscope.
Harvesting and fixation of developing rat lung tissue for
immunohistochemistry
1. Timed pregnant Sprague-Dawley rats (Harlan, UK) were euthanased at the
appropriate time points using carbon dioxide.
2. Embryonic day 16: The foetuses were harvested and placed in 4%
paraformaldehyde solution at 4°C for 2 hours then switched to 30% sucrose
solution and left overnight at 4°C.
3. Embryonic day 17 - day 21: Lungs were removed separately and placed in a
4% paraformaldehyde fixative solution containing 10% OCT (vol/vol). After 2
hours at 4°C, tissue was switched to sucrose and left at 4°C overnight.
Page 40
Immunohistochemistry for fluorescence microscopy
Protocol for staining frozen sections: See table 4 for a list of primary antibodies.
Alexa secondary antibodies (table 6) were obtained from Molecular Probes, Invitrogen
Ltd, UK.
1. Frozen sections were treated with Blocking Buffer with Triton (BBT) for 10
minutes then washed three times with Phosphate Buffered Saline (PBS)
2. 100/zl of primary antibody solution was added to each slide for 20 minutes
(primary antibodies were diluted at 1:100 except for anti-RTl40=l:50, and anti-
pro-SP-C=l:10).
3. Tissue was washed three times with PBS before adding 100/zl secondary
antibody (dilution 1:100 in BBT for Alexa secondaries) for 15 minutes.
4. Washing was carried out as before and 100/zl of TO-PRO-3 (Molecular Probes,
Invitrogen Ltd, UK) added for 10 minutes (dilution 1:1000 in PBS).
5. After further washing, a coverslip was mounted using fluorescence mounting
medium (DakoCytomation, UK).
Table 6. Secondary antibodies used in immunohistochemistry
Primary antibody Antibody Isotype Alexa secondary antibodies used
MMC4 Mouse IgG2a Alexa Fluor 546 goat anti-mouse IgG2a (A-21133)
Anti-RTII70 Mouse IgG3 Alexa Fluor 647 goat anti-mouse IgG3 (A-21243)
Anti-Pro-SPC Rabbit polyclonal Alexa Fluor 488 goat anti-rabbit IgG (A-l 1070)
Anti-RTI40 Mouse IgG 1 Alexa Fluor 488 goat anti-mouse IgG 1 (A-21121)
Alexa Fluor 647 goat anti-mouse IgGl (A-21240)
Anti-SPD Rabbit polyclonal Alexa Fluor 488 goat anti-rabbit IgG (A-l 1070)
Protocol for staining cells fixed on coverslips used in cell culture:
The protocol for staining coverslips with adherent ATII is similar to that for
frozen sections with the following modifications:
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1. Cells were fixed at the appropriate experimental juncture using 4%
paraformaldehyde solution. Before staining, fixative solution was washed off the
cells using PBS.
2. Blocking buffer, and antibody application were carried out as above.
3. The staining solutions were applied to the cells by retrieving the coverslip from
the bottom of its 24-well plate and placing it cell-side down onto a piece of
laboratory film (Parafilm, Pechiney Plastic Packaging, Chicago USA). A small
drop of the required solution (antibody, blocking buffer etc.) was pre-positioned
on the film and formed a capillary across the cells.
4. Washing was done by gentle irrigation of the coverslip while holding carefully
in fine forceps.
Confocal microscopy using the Zeiss LSM 510
Basic laser/filter set up: Images were captured using confocal laser scanning
microscopy with the Zeiss LSM 510 scanning head fitted to an Axiovert 100M research
microscope. Both are fully motorized and can be controlled via the LSM software.
Three lasers were used: Argon/Krypton (488nm), Helium/Neon (543nm), Helium/Neon
(633nm). The Alexa secondary antibodies used for staining have emission spectra
which peak at wavelengths 546nm (Alexa 546 appears red), 488nm (Alexa 488 appears
green) and 647nm (Alexa 647 appears blue). Alexa 647 emissions were filtered through
a Low Pass 650nm filter, Alexa 488 emissions through a Band Pass 500-530nm filter,
and Alexa 546 emissions through a Band Pass 565-615 filter (figure 5). Images were
captured as three channel (red, green, and blue) 8-bit grey scale TIFFs, at a resolution of
1024 xl024 pixels. A further 'transmitted', or visible light image of the specimen was
also captured to record morphology at the light level.
Multi track versus single track scanning with the Zeiss LSM 510
Scanning of each channel was performed sequentially (multi-track imaging) - that is the
lasers were used one at a time, exciting the specimen with each wavelength of laser
light and detecting emission before moving on to the next. This was a crucial part of the
image acquisition strategy, as the alternative technique - simultaneous (single track)
excitation and detection at all wavelengths used can lead to serious artefactual 'spectral
Page 42
spillor cross-talk of signal between channels. In our system, cross-talk occurred
particularly between the red and green channels during single track scanning, but was
effectively eliminated by multi-tracking. This problem is illustrated below. Figure 5A
shows the excitation spectra for the fluorophores used. The band pass filter system used
in detection limits the signal seen by each detector to excitation of the fluorophore of
interest. The success of this configuration allows independent detection of multiple
fluorophores simultaneously during a single scan, reducing scan times and
photobleaching of the specimen. A problem occurs using this single track technique
when the excitation spectra for the fluorophores used significantly overlap - in this case
the Alexa 488 and Alexa 546 fluorophores (figure 5B). Alexa 488 emission excited by
the Argon/Krypton 488 laser is detected mainly in the 'green' channel, whose
sensitivity is windowed around the peak signal wavelength (500-530nm). Single track
scanning using Alexa 488 and Alexa 546 would mean simultaneous detection of the
signal generated by excitation of the 546 fluorophore windowed around its peak (565-
615nm). It can be seen from the figure that the 'red' signal is potentially contaminated
by the 'tail' of the 'green' fluorophore emission. In practical terms, this means that
imaging a specimen with a strong Alexa 488 (green) signal by single tracking can result
in the appearance of a co-localised positive signal in the 'red' channel, in the absence of
any actual staining with a 'red' (565-615nm emitting) fluorophore. By exciting and
detecting each channel separately, multi-track scanning eliminates this type of cross¬
talk.
Capturing tiled images using the Zeiss LSM 510
In order to capture images of large contiguous areas of sections at high magnification
image tiling was used. Large images composed of a number of smaller tiles allow
detailed examination of a significant area of tissue, scanned at the same time, with the
same microscope settings. Tiling facilitates quantification by measuring or counting
without the bias introduced by simply choosing a number if interesting looking fields of
view. The procedure adopted was as follows:
1. A 'scout' image was captured using the x5 objective. A tile was created using 25
contiguous fields of view (i.e. 5x5 fields). 2.
2. This tile was inspected and areas of interest determined and marked - the LSM
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510 is able to record stage positions and return to a given point providing the
slide is not moved.
3. Higher powered views (20x or 63x objectives) were then obtained, and further
high magnification tiles captured which could be further processed e.g. cell
counting, quantification of antibody colocalisation etc. The maximum size of tile
obtainable using the Zeiss LSM 510 system is 4096x4096 pixels. This equates to
4x4 fields of view using the x63 objective (a specimen area of 585pm2), or 4x4
fields of view using the x20 objective (specimen area 1843pm2) using the
capture settings detailed above.
Image Density Slicing using Openlab
Crucial to counting the numbers of a particular cell type or determining the area of
epithelial surface colocalising particular proteins was the facility to isolate the areas of
an image which are positively stained with a given fluorochrome. This was achieved
using the Density Slice ... and Boolean Operations ... functions in Openlab 3.5.2. Tiled
images were first opened in Openlab after reducing the size to a maximum of
4080x4080 pixels (This was done using GraphicConverter Picture>Size>Add!Remove
Margins ... Openlab is unable to deal with larger images). The RGB TIFF tiles were
then split into their constituent red green and blue channels (Layers>Split RGB). Each
layer could then be analysed to select areas above a given intensity threshold using the
Image Density slice function. The threshold for 'positivity' was arrived at by polling the
pixel value of a positive area using the HSI (Hue, Saturation, Intensity) Colorspy palette
or by selecting a positive area (Region of Interest - ROI) in the image (e.g. a positively
stained cell) and using the Grab from ROI function in the Density Slice dialog.
Positively stained areas in the red, green and blue channels could be selected using the
Density Slice function, and a further layer produced containing a simple single colour
outline of the positive parts of a given image - a so called binary layer. This Binary
layer could then be overlaid on the original image and the positive areas counted or
measured using Openlab's Measurement tools. Boolean Operations ... allow binary
layers to be combined in useful ways - to highlight colocalisation for example. Openlab
is able to look at the binary layer for all positive 'green' (e.g. Alexa 488 labelled
antibody) staining areas AND all 'red' (e.g. Alexa 546 labelled antibody) staining areas.
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The resulting combined binary layer shows only those pixels in the image containing
green and red intensities above the positive threshold value that is, the areas
corresponding to positive staining with both antibodies.
Importantly, images used for quantification were not digitally enhanced in any way.
Pixel intensity values were left unaltered after image capture to avoid the introduction
of artefact.
Cell counting with Openlab
Cultured cells were fixed and stained as detailed above. A 'tiled' image of an area of
cells was then obtained using the confocal microscope. Areas of positive fluorescent
staining or colocalisation could then be determined using density slicing in Openlab.
Overlaying the binary map showing the cells of interest on the DIC image of all of the
cells enabled counting using the Measurements facility in Openlab. Because of cell
clumping, the DIC image alone was not always sufficient to provide an accurate
denominator for cell counts. The addition of a channel showing staining of all nuclei
(with TO-PRO-3) increased reliability of counts.
Quantification of epithelial surface area staining using Openlab.
Analysis of the proportion of the alveolar epithelium covered by cells of a particular
phenotype cannot be done by global biochemical analysis of lung proteins. In order to
make a quantitative assessment of alveolar epithelial composition, the epithelial cells
must be typed, and then some form of measurement made. I chose to use length of
alveolar epithelial surface visible in a section of lung as a representative measure of the
alveolar epithelial area present. In particular, as a measure with which to compare
control lungs and inflamed lungs. The total length of exposed alveolar epithelial surface
was imaged using the tiled image capture technique detailed above. This surface was
then traced using Openlab and a Wacom graphics tablet and pen (figure 6A, C).
Density slicing to create binary layers demarcating the positively staining areas of
epithelium allowed these also to be measured in the same way (figure 6B, D). The
contribution to the alveolar epithelial cell surface made by cells of various immuno-
phenotypes could be quantified as a percentage of the total exposed surface. This
process was repeated for control lung sections, and sections from inflamed lungs.
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Localisation of different proteins in the cytoplasm of epithelial cells and on the
epithelial cell membrane surface was investigated using this technique.
Z-plane scanning and 3D reconstruction with Volocity
A particular advantage of the confocal laser scanning microscope (LSCM) is its ability
to produce optical sections - each having a very small depth of field, with no
contribution to the section from out of focus regions of the specimen above or below the
plane of interest. This feature, coupled with the ability to scan below the surface of
tissue specimens allows capture of a series of sections which may be arranged to form
an image 'stack' viewable as a three dimensional image. I employed this range of
techniques to investigate the 3D distribution of cell-selective proteins on the cells of the
alveolar epithelium in control and inflamed lungs. Cells or tissue sections were fixed
and stained in the usual way. Multi-track scanning was performed as before, but with
the additional step of determining the positions of the top and bottom of the specimen
by scanning at different focal planes (i.e. different z-positions). The specimen was then
scanned at a series of different levels to create an image stack. The number of images in
the stack, and vertical distance between sequential images (z-step) were adjusted to
achieve an image of sufficient z-resolution to be useful, while avoiding destructive
photobleaching of the specimen. As the laser scans the specimen, it is selectively
bleached in the xy plane and non-selectively bleached in the z plane. As the specimen is
scanned one plane at a time, not only is that plane bleached, but all other cross-sectional
planes above and below are also bleached. There is of necessity a compromise between
better z-plane resolution and 'total slice capacity' (or the fixed number of images that
can be sampled from a specimen before the data becomes artefactual).
Deconvolution of image stacks using Huygens 2 (SVI) software
For three-dimensional viewing of alveolar wall membranes where resolution of the final
image was critical, image stacks were acquired using Nyquist settings (the Nyquist
criterion determines the minimal sample density needed to capture all information from
the microscope into the image. When the sampling distance is larger than the Nyquist
distance information about the image is lost). The raw data were deconvoluted using
Huygens 2 (SVI) software and reconstructed and analyzed for co-localization using
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Imaris 4.0 Software (Bitplane AG, Zurich)(Duncan, Greaves et al. 2003).
Deconvolution involves the recovery of information about an object from an image that
is degraded by blurring and noise. In LSCM the blurring is largely due to diffraction
limited imaging by the instrument; the noise is usually photon noise. Deconvolution
involves the application of An MLE (Maximum Likelihood Estimation) algorithm to the
image stack dataset, which calculates the object distribution with the highest likelihood
of having produced the output image, taking into account the nature of the noise and the
imaging properties of the microscope.
Rat haemorrhagic Shock Model
The rat haemorrhagic shock model was developed jointly with Stuart McKechnie.
Experiments were performed jointly, but subsequent biochemical analysis of broncho-
alveolar lavage fluid was performed by Stuart McKechnie.
Animal preparation: Specific pathogen-free male Sprague-Dawley rats (250-300g,
Harlan UK) were anaesthetised using intraperitoneal injection of midazolam (5mg/kg)
and ketamine (75-100mg/kg) and placed supine on a temperature-regulated heating pad.
After shaving, a transverse incision of the neck was made and the trachea, right
common carotid artery and left jugular veins exposed by blunt dissection. The common
carotid was clamped proximally and cannulated using PE50 tubing (Becton Dickinson)
facilitating continuous measurement of arterial blood pressure using a modified Propaq
Encore monitor (WelchAllyn, Bucks, UK), and arterial blood sampling. The left
internal jugular vein was cannulated in a similar manner, but without proximal
clamping, to allow central venous pressure monitoring (using the Propaq as above) and
administration of drugs and fluids. Anaesthesia was maintained by an intravenous
infusion of Propofol (0.5mg/kg/min) and muscle relaxation with pancuronium bromide
(2mg/kg/h). Normal saline was administered intravenously such that intravenous fluids,
including medications, totalled 1.5ml/h. A tracheostomy was performed and the trachea
cannulated using an 18G monoject blunt needle (Harvard Apparatus), and rats
ventilated using a volume-controlled ventilator (Small Animal Ventilator Model 683,
Harvard Apparatus). A tidal volume of 6ml/kg, positive end expiratory pressure (PEEP)
of 5cmH20, inspired oxygen fraction (Fi02) of 1.0 and a respiratory rate of 55-60
breaths/min were delivered and adjusted to maintain a pH of between 7.3 and 7.45.
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Experimental Protocol (figure 8): After a 30 min stabilisation period, blood was
removed from the carotid artery in 500/d aliquots, lowering the mean arterial pressure
(MAP) to 30-40mmHg. This level of haemorrhagic shock was maintained for 30 min,
followed by resuscitation over 15-30 minutes using warmed intravenous normal saline
to restore the MAP to >80mmHg whilst maintaining a CVP of <10mmHg. The variation
in MAP over the course of a typical experiment is shown in figure 8 (B). Animals were
subsequently ventilated for an additional 4 hours and then exsanguinated. Blood was
collected from the abdominal aorta and the lungs lavaged with 2xl0mls of sterile
endotoxin and Ca/Mg free PBS to obtain BAL fluid for analysis. Control animals
underwent surgery without subsequent haemorrhage. Lavage fluid was analysed to
determine total protein content, differential cell count, and MMC4 and RTI40 protein
content. MMC4 and RTI40 proteins were quantified using an ELISA-based dot blot
assay as previously described (McElroy, Pittet et al. 1995; Boylan, Pryde et al. 2001).
BAL protein content assay
Protein concentrations in aqueous solution were determined using the Bio-Rad, also
known as Bradford (Bradford 1976), protein assay. This is a dye-binding assay based on
the concentration-dependent shift of the absorbance maximum of an acidic solution of
Coomassie Brilliant Blue G-250 from 465 nm to 595 nm upon binding protein. Protein
concentrations were obtained from the linear range of a standard curve constructed by
plotting absorbance against concentration (0-1.4 mg/ml) of bovine serum albumin.
Absorbance of samples was read at 630 nm using a plate reader.
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Results 1: Control lung alveolar epithelium
Introduction
Control lung sections were stained with a panel of antibodies in order to establish their
specificity when used in combination to identify ATI and ATII cells (table 4). The
distribution of staining was examined in 2D and 3D using laser scanning microscopy,
and the imaging technique developed to avoid confounding sampling artefact.
Antibodies fell into two main groups: those which stained membrane associated
proteins, and those having an affinity for cytoplasmic/secreted proteins:
The phenotype of the alveolar epithelium in control lungs defined using anti-
RTI40, MMC4, anti-RTII70, anti-Pro-SP-C, and anti-SP-D antibodies
Membrane associated proteins: RTI40 is a membrane associated protein expressed on
the apical surface of ATI cells (Dobbs, Williams et al. 1988). Examination of control rat
lungs stained with anti-RTI40 showed that the majority of the epithelial surface area
was comprised of RTI^ positive cells (figure 8). MMC4 is a monoclonal antibody
(mab) which has been shown in the lung to stain only the apical membranes of ATII and
Clara cells (Boylan, Pryde et al. 2001). Anti-RTII70 is also a ATII cell membrane
specific mab (Dobbs, Pian et al. 1997). Control rat lungs displayed MMC4/RTII70
positive cells at the corners of the alveolar air spaces, flanked by RTI40 positive cells
(figure 8C). Small airways that appeared in control lung sections featured epithelial
cells with typical Clara morphology (cuboidal non-ciliated cells) that were also MMC4
positive at their apical surfaces but did not stain with RTII70 (figure 8D).
Secreted intracellular proteins: Surfactant protein C (SP-C) is a hydrophobic
peptide that is specific to the lung (Beers, Wali et al. 1992). Production of SP-C occurs
exclusively in ATII cells involving the proteolytic cleavage of a larger molecule pro-SP-
C (p-SP-C) (Beers, Wali et al. 1992). Anti-pro-SP-C antibody is therefore a very useful
ATII cell specific marker. I found that p-SPC was localised to the cytoplasm of cuboidal
cells in a typical ATII position at the corners of the alveoli, (figure 9). Cells staining
with p-SP-C in the cytoplasm also stained positively for MMC4 at their apical
membranes, and did not stain with RTI40, confirming their ATII phenotype (figure 9).
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Similarly surfactant protein D (SP-D) is secreted by ATII cells, but in contrast to p-
SP-C, is also produced by Clara (non-ciliated bronchiolar epithelial) cells (Wong,
Akiyama et al. 1996). SP-D is not localised to lamellar bodies but is found in the
endoplasmic reticulum of ATII cells, and in the secretory granules of Clara cells.
Though it is highly expressed in conducting airways of rats SP-D is found sparsely in
the conducting airways in humans (Mason, Greene et al. 1998). In the control sections
examined SP-D was present in the cytoplasm of typical ATII cells (figure 10), alveolar
macrophages also appeared to have a low level of staining (figure 10A white arrows).
This is consistent with the finding that SP-D has a significant role to play in innate
immunity in the lung, and has receptors on the surface of a variety of cell types
including alveolar macrophages (Miyamura, Leigh et al. 1994; Holmskov, Lawson et al.
1997).
Three dimensional imaging of control lung tissue
Examination of control lung tissue using laser scanning confocal microscopy allowed
optical slicing of tissue, and reconstruction of images in three dimensions using imaging
software (Volocity 3.0, Improvision UK). This technique was useful in showing the
non-uniform distribution of proteins in the cytoplasm and on cell membranes.
The problem of depth: Frozen tissue sections were variable in thickness, and range
from around 3//m to 10//in. This size approaches the order ofmagnitude of the diameter
of a ATII cell apical surface (around 7//m). It is possible for positively stained cells to
be invisible to the LSCM if scanning is performed in only one z ('vertical') plane. This
is illustrated in (figure 11), where the alveolar epithelial surface has been sectioned en
face. Here a ATII is visible staining characteristically with MMC4 and RTII70 giving a
pink circular appearance to the apical membrane, surrounded by green RTI40 staining
ATI cells (figure 11A). If the same section is scanned a few microns lower in the z-
plane the ATII cell almost disappears, as the optical section is now cutting through the
tissue below the level of the apical membrane staining
Image stacks as a solution to the problem of depth: (figure 11D) shows a 3D
reconstruction of the field of view that has been rotated to give perspective. This 3D
volume rendered image is derived from a stack of 60 optical sections, each aligned in
the xy plane. Volume rendering is a technique whereby the object or phenomenon of
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interest is sampled or subdivided into many cubic volume elements or voxels. A voxel
is the 3-D counterpart of the 2-D pixel and is a measure of unit volume. Each voxel is
assigned an intensity value and is represented by a unit cube. The 3-D voxel sets are
assembled from multiple 2-D images (i.e. the LSCM image stack), and are displayed by
projecting these images into 2-D pixel space - displayed on the 2-D computer screen.
Volumes rendered in this manner have been likened to a translucent suspension of
particles in 3-D space. The 3-D reconstruction can be interrogated to show the
appearance of an object from different perspectives, or 'cut' in any plane to show the
internal structure of an object. This is illustrated in (figure 12) where the 3-D image is
shown as if seen from different points of view, providing useful information about the
spatial relationship of the cells in the tissue section.
More accurate quantification of sections: The LSCM scans a thin optical section in a
plane perpendicular to the optical axis of the microscope. The stage is carefully
balanced with a spirit level prior to each session so that the microscope slide is parallel
to the plane of optical sectioning. Because the tissue sections to be examined are seldom
absolutely flat, however, the specimen on the slide will often be partially out of focus
during scanning - particularly when capturing lower magnification images (x20
objective or less) or tiled images covering large physical areas (often almost 2mm2).
(Figure 13) shows the consequences of scanning an object with an (exaggerated)
uneven surface with a thin focal plane, The schematic (figure 13D) illustrates that
because of the confocal nature of the image, only the portion of the image to the left of
the field of view is in focus (and therefore brighter) when scanning at plane z1, whereas
the right of the field is best seen at z2. Combining images taken at both planes includes
all of the information on the section. (Figure 13A, B) show a section of control lung
scanned with a x20 objective. Five optical slices were taken through the slide - the
tissue section is approx 9.6//m thick. The green and red channels (RTI40 and MMC4
staining respectively) illustrate the point above. Combining all layers in image C allows
all of the cells present to be seen. This type of approach was employed in obtaining
images of frozen lung sections or cells for quantification. It is critically important in
order to avoid loss of data from tissue analysis that images at different z-planes through
the specimen are obtained for each field of view. Images can then be combined (by
linear averaging), or a fully representative image selected if one exists, for use in
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analysis.
3D distribution of antibodies in control lung:
Tissue block staining in 3D: In view of the difficulties experienced in obtaining good
frozen sections of control lung tissue I decided to investigate whether the distribution of
the antibodies used was the same in paraformaldehyde fixed lung that had not been
infiltrated with OCT or cut using the cryostat. Lung tissue was obtained from adult rats,
fixed using paraformaldehyde and cut into 5mm cubes in the usual way. Cubes could
then be stained using minor modifications to the standard immunohistochemistry
protocol. Tissue was fixed to the bottom of a small petri dish using cyanoacrylate
adhesive (Super Glue, Loctite UK) and immersed in PBS. The specimen was then
imaged using a Zeiss LSM 510 scanning head fitted to an upright Axioplan research
microscope. A x40 water 'dipping' objective was then used to image the tissue block as
deeply as possible under the surface of the specimen, creating an image stack for 3D
reconstruction. (Figure 3) shows two different views of the same piece of tissue 146/<m
xl46/<m in cross-section by 165.8//m deep. This sample of control lung has been
stained with anti-RTI40 (green), MMC4 (red) and anti-RTII70 (blue). Image quality is
limited by antibody penetration into the tissue as well as LSCM capture and bleaching.
It is clear that the relationships between the apical membranes of ATII cells (pink),
surrounded by ATI cells (green) seen in tissue sections is maintained when imaging an
intact cube of tissue without frozen sectioning.
Immunophenotyping - staining controls
Auto-fluorescence
Although previous authors have described the lung as prone to auto-fluorescence under
examination with the fluorescence microscope (and recommend various measures to
overcome this) I found that fixation using the methods employed here resulted in no
significant signal when fixed, unstained tissue was viewed using the methods detailed
above.
Secondary only negative controls
The presence of well-demarcated areas of staining using the antibody combinations
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employed here suggests low levels of 'background' staining. This was confirmed by
incubating control and injured tissue with secondary antibody in the absence of a
primary. Staining and imaging using the methods detailed above did not result in any
significant secondary only signal.
Isotype-specific negative controls
To further ensure that the primary antibody staining demonstrated here was biologically
significant, and not non-specific binding, further control staining of control and injured
lung was performed using unrelated primary antibodies (having the same isotypes as the
primaries in our panel) and the same secondary antibodies (with appropriate isotype
specificity) used in the experimental work detailed here (table 7). Isotype-specific
control antibodies were obtained from Stratech Scientific Ltd. and are purpose made
negative controls raised against haptens not normally present in human or animal tissue.
Both normal lung tissue, and injured lung sections showing significant inflammatory
infiltrate were stained and imaged using the LSCM (following the same protocol as the
other experimental work detailed here). Again, no staining was visible either in control
lungs or injured lungs with inflammatory infiltrate.
Table 7. Isotype specific primary antibody negative controls
Negative control isotype Clone Ref. number
mouse IgGl NCG01 NC-748
mouse lgG2a NCG2A.01 NC-1390
mouse IgG2b NCG2b.01 NC-1391
mouse IgG3 NCG3.01 NC-1357
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Results 2: Repairing lung alveolar epithelium
Introduction
Having characterised the normal rat lung alveolar epithelium the next step was to
investigate the composition of the epithelium during recovery from an acute injury. A
rat model of S. aureus induced acute lung injury was used, and compared to a similar
model using S. pneumoniae. Analysis of the composition of the recovering alveolar
epithelium determined by immunohistochemistry was compared to ultrastructural
imaging by electron microscopy.
The phenotype of the alveolar epithelium following S. aureas-induced lung
injury
Instillation of S. aureus suspension into the distal airways of the lung causes
inflammation and consolidation in the alveolar airspaces. This injury induces a localised
inflammatory reaction that is resolving by 3 days. Lungs examined macroscopically at
this time point exhibit areas of darker tissue - visible to the naked eye - that correspond
to the inflamed regions, (McElroy, Cain et al. 2002). Other parts of the lung appear
normal (referred to here as non-inflamed regions). Examination of the morphology of
these inflamed regions (by light microscopy on frozen lung sections, or haematoxylin
and eosin stained paraffin-fixed sections) reveals three morphologically distinct sub
regions of lung tissue: (figure 14). These sub regions exhibited (i) thickened alveolar
walls with some inflammatory cells in the airspaces (ii) consolidated regions in which
the small airspaces are filled with cells and debris - here the alveolar wall is not distinct
from the airspaces or the inflammatory cell influx (iii) regions which are
morphologically indistinguishable from control lungs. The panel of antibodies reacted
with the alveolar epithelium lining thickened alveolar walls and control-like alveolar
walls but not cells in with the consolidated regions.
Alveolar walls in the inflamed regions were lined by RTI^-positive cells (ATI cells)
and MMC4/RTII70-positive cells (ATII cells) (figure 15A). However, the surface area
of the alveolar walls covered by MMC4/RTII70-positive cells (ATII cells) was increased
by over 5-fold in S. aureus-injured lungs in comparison with controls (figure 16B). In
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contrast, the surface area of the alveolar walls covered by RTI40-positive cells (ATI
cells) in S. aureus-injured lungs was significantly decreased in comparison with control
lungs (figure 16A). The expression of pro-SP-C and SP-D in MMC4/RTII70-positive
cells was not uniform. Some groups of MMC4/RTII70-positive cells were positive for
pro-SP-C and SP-D while other groups of MMC4/RTII70-positive appeared to be either
negative or express very low levels of pro-SP-C and SP-D (figure 17)
In areas of the alveolar epithelium associated with increased numbers of ATII cells I
also observed alveolar membranes that co-expressed a unique combination of markers,
RTI40 and MMC4 (figure 15A, D). Furthermore, three-dimensional analysis of
RTI40/MMC4-coexpressing membranes using confocal laser scanning microscopy
confirmed co-localization of these markers on the same membrane (figure 18).
Deconvolution of high magnification images of the epithelial surface in inflamed
regions of the lung confirms that in areas of RTI40/MMC4-coexpression, the proteins
colocalise at the limits of resolution of the LSCM system i.e. around 0.5/<m. (figure
20). Quantitative analysis using Openlab demonstrated that RTI40/MMC4-positive
membranes in S. aureus-'m]wtd lungs accounted for approximately 3% of the alveolar
surface in the macroscopically injured region (figure 16, figure 6). Approximately one
third of RTI40/MMC4-positive membranes also expressed RTII70 (figure 19).
RTI40/MMC4-positive cells either did not express pro-SP-C, or expressed pro-SP-C at
much lower levels, in comparison with RTII70/MMC4-positive cells (ATII cells) (figure
17A). The small area of RTI40/MMC4-coexpressing epithelium in control lungs was
limited to areas where ATI cells (RTI40-positive) and the apical membrane of ATII cells
(MMC4/RTII70-positive) were adjacent. These areas are likely to represent the interface
of separate red and green staining membranes within the same voxel (the voxel or
"volume element" is the 3D conceptual counterpart of the 2D pixel - the smallest non-
divisible element in a 3D digital image) rather than true co-expression of proteins on the
same membrane (figure 20, figure 18). Quantification of the lengths of continuous
RTI40/MMC4 positive membrane gave further evidence that the areas of apparent
RTI40/MMC4 colocalisation in control lungs are unlikely to represent intermediate
phenotype cells co-expressing these membrane antigens. Measurement of the apical
membrane length of ATII cells in control rat lungs in our model gives a mean value of
7/rni (1.54-22.8/<m), which is in keeping with other investigators' findings (e.g. Hais et
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al. measured a mean ATII cell luminal surface area of 62pm per cell - excluding
microvilli - which gives a mean cell luminal surface diameter of ~8.9/im if the surface
is assumed to be roughly circular (Haies, Gil et al. 1981). (figure 16) shows a frequency
histogram of the individual lengths of RTl4o/MMC4 positive membrane measured in
control vs. inflamed lungs. In control lungs the majority of RTI40/MMC4 positive
segments were tiny, measuring much less than half of the typical diameter of the ATII
cell apical membrane (94% of segments were less than 3pm in length). In inflamed
lungs, however, these intermediate phenotype segments of membrane were almost all
greater than 5pm. This is consistent with the idea that in control lungs apparent
RTI40/MMC4 staining represents the limits of the imaging system to resolve adjacent
structures rather than intermediate phenotype cells. In inflamed lungs, however, the
pattern suggests multiple adjacent cuboidal cells (or fewer numbers of larger flattened
cells) expressing RTI40/MMC4 antigens on their surface membranes.
Performing a similar examination of the lengths of epithelial cell membrane with a
typical ATII cell phenotype (i.e. RTII70/MMC4) in control and inflamed lungs gave
expected results. As would be predicted, the bulk of the segments of control epithelium
with ATII phenotype were around l-\Apm in length (figure 21A). A number of
segments were smaller than a single cell (though less than 1% were shorter than 3pm),
reflecting the common situation where the tissue section has cut through the roughly
circular apical membrane of the cell along a chord rather than a full diameter. In
inflamed lungs, the mean MMC4 segment is ~15//m in length (0.6-84.3/<m) with long
continuous stretches of ATII phenotype cells (figure 21B). These findings are
consistent with the widely reported phenomenon of ATII-cell 'hyperplasia' after
alveolar epithelial injury (Adamson and Bowden 1974; Evans, Cabral et al. 1975).
The phenotype of the alveolar epithelium following S. pneumoniae-induced
lung injury
Using a protocol similar to the S. aureus pneumonia model, S. pneumoniae was used to
cause an injury to the rat lung alveolar epithelium. At 24 hours after bacterial
instillation, inflammation and repair were evident in the lungs. Sections were stained
using the same panel of antibodies as previously and examined using the LSCM. A
significant inflammatory infiltrate was evident in many alveolar airspaces (figure 22A).
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Most of the alveolar epithelium was covered by RTI40 positive ATI cells, with MMC4
positive ATII cells also visible (NB inflammatory cells in the airspaces are also stained
red with MMC4). A population of RTI40/MMC4 positive intermediate phenotype
alveolar epithelial cells was also visible.
Ultrastructure of the alveolar epithelium in inflamed lungs
Electron microscopy of lung tissue from control animals showed normal lung
ultrastructure (figure 23). Long thin attenuated ATI cells form the majority (~95%) of
the surface area. These cells characteristically showing a paucity of organelles with only
the prominent nuclei evident (figure 23B). Cuboidal ATII cells were positioned in the
corners of the alveoli, flanked by ATI. The sine qua non of ATII cells is presence of
surfactant containing lamellar bodies that resemble the layers of an onion in cross-
section (figure 23A, D). In contrast with control lungs the alveolar walls of inflamed
lungs 3 days after S. aureus-mjury, were covered by mostly cuboidal epithelial cells in
(figure 24). Some epithelial cells had more typical ATII cell features (lamellar bodies,
apical microvilli) but appeared to be spreading, and had reduced perinuclear cytoplasm
(figure 24A). Other cuboidal epithelial cells lacked both microvilli and lamellar bodies
(figure 24 B).
In some places ATI cells (or ATI-like cells) were observed overlying ATII cells. Where
this occurred, high magnification views of the ATII cell apical surface showed a double
membrane (figure 24C).
Some ATI cells also had an occasional microvillus. These ultrastructural studies
demonstrated that the alveolar wall in inflamed regions from S. aureus-treated lungs
was thickened secondary to a relative increase in the numbers of ATII-like cells.
Inflamed regions also and contained a population of epithelial cells not found in control
lungs with features consistent with an 'intermediate' phenotype.
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Results 3: Alveolar epithelial cells in vitro and in development
Introduction
The changes in phenotype of freshly isolated ATII cells with time in a standard
submerged cell culture environment were examined. The progression from a ATII
phenotype to a ATI-like phenotype in culture was characterised using the same
immunophenotyping techniques employed in both the control and injury/repair models
above. Alveolar epithelium from rat lungs at various stages of development were also
imaged. I sought to determine whether a subset of alveolar epithelial cells displaying the
same combination of both ATII and ATI markers seen in repair would be detectable in
culture and/or during alveolar development.
Analysis of freshly isolated type II cells - modified Papanicolau staining
Immediately after isolation cells were cytospin and allowed to air dry. Subsequent
staining allowed quantification of the proportion of ATII cells isolated, and the numbers
of contaminating cells of other lineages. Characterisation was performed initially by
modified Papanicolau (Pap) staining of the cytospin cells (figure 25A). Cells were
counted at high magnification using a xlOO oil immersion objective. Cells containing >
4 dark staining inclusion bodies (lamellar bodies) were counted as being ATII cells
(Dobbs 1990), other cell types were identified by characteristic morphological features.
This method gave a figure of 66% ATII with approximate proportions of contaminants
as shown (figure 25B). Cell types were identified by light microscopy. A 'running
mean' was used to estimate the total number of cells needed to count in order to reach a
stable figure for the proportion of ATII cells.
Phenotype of Cultured Alveolar Epithelial Type II cells
Freshly isolated ATII cells co-expressed ATII cell markers, RTII70 and MMC4 but not
RTI40. By day 5 in culture, all the cells expressed RTI40 but not RTII70 or MMC4. This
change in expression of cell type specific protein expression was also accompanied by a
change in morphology as cells flattened, spread, and became confluent (figure 26,
figure 27). On Day 1 many flattened, spreading cells were weakly positive for RTI^
with a sub-population of cells (5.9 % ± 1.4 %, n =3) strongly positive for both RTI40 and
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MMC4 (figure 28). I did not detect RTII70 at Day 1 of culture. These data suggest that
the kinetics of cells with the RTI40/MMC4-phenotype are consistent with their role as
transition cells (i.e. not present in isolated ATII cells or when the cells are ATI-like and
express RTI40). 3D visualisation of RTI40/MMC4 positive cells revealed that these cells
had begun to spread and take on a more flattened shape than the MMC4 expressing
ATII (figure 29). RTI^ signal appeared to be localised to the spreading edge of the cells
(figure 30).
The alveolar epithelium in development
Developing rat lungs were stained with MMC4 and RTI40 to see if MMC4/RTI40
positive cells could be detected in the alveolar epithelium. At day 16 (El6) the size of
the embryo enabled visualisation of an entire saggital section (figure 31). No MMC4
staining was seen at this time point, and no RTI^ staining was visible in the lung. The
choroid plexus and parts of the central nervous system did stain positively for RTI40 as
previously described (Williams, Cao et al. 1996) (figure 31A, B). At El7 the embryonic
lung was dissected out and visualised in section, some tubules were lined by cuboidal
cells with RTI40 positive apices, but no significant MMC4 staining was present (figure
32). The embryonic lung was beginning to look much more adult by E20 (figure 33).
RTI40 lined 'airspaces' were obvious, with ATII cells staining with both MMC4 and
RTI40. Alveolar septae were still very thickened and cellular, with ATII cells grouped in
clusters rather than occurring singly as in the mature lung. Non-ciliated cells in the
terminal bronchioles could also be identified by MMC4 apical staining (Boylan, Pryde
et al. 2001). Lungs from pups at post-natal day 3 (PN3) provided the first evidence of
MMC4/RTI4Q positive cells (figure 34). Cells with an intermediate phenotype were
visible in the epithelium of the terminal bronchioles, flanked by non-ciliated MMC4
positive cells, occasional cells at the broncho-alveolar junction were RTII70 positive in
addition to MMC4/RTI40 (figure 34). The alveoli were lined by RTI40 positive ATI cells
and MMC4/RTII70 positive ATII cells but did not show any intermediate MMC4/RTI4<)
positive cells. Lungs were also surveyed on post-natal days 4 and 5 (figure 35). The
process of alveolar remodelling continued at these time points, with thinning of the
alveolar walls. Despite the appearance of expansion of the alveolar epithelium no
MMC4/RTI40 positive cells were seen in the alveoli. MMC4/RTII70 expressing ATII
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cells became more scattered and widely spaced with 3D visualisation showing them
protruding markedly into the alveolar airspace - a feature that is less pronounced as the
lung matures.
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Results 4: Haemorrhagic Shock - a model of indirect acute lung injury
Introduction
Having examined the repairing alveolar epithelium in a model of direct acute lung
injury (i.e. bacterial instillation), we developed a model of indirect lung injury with a
view to comparing the process of repair after direct versus indirect epithelial insult. The
degree of alveolar epithelial injury induced by profound hypotension for 30 minutes
followed by positive pressure ventilation for 4 hours was assessed by examining BAL
fluid for evidence of lung leak (total protein content), and epithelial cell specific protein
markers. These measures have previously been found to correlate with histological
measures of epithelial damage in a model of direct lung injury (McElroy, Pittet et al.
1995). A differential cell count was also performed on BAL fluid to quantify the
inflammatory response to injury in the lung. The use of epithelial cell type specific
markers to assess the severity of alveolar injury offered the advantage of further
indicating the degree to which particular epithelial cell populations had been affected
(McElroy and Kasper 2004). Although the duration of our protocol was too short to
expect detectable epithelial repair, it represents the first step in the process of
developing a recovery/repair model.
Alveolar epithelial injury after profound hypotension followed by fluid
resuscitation and positive pressure ventilation
Animals were anaesthetised and surgery performed as detailed above (figure 8). Blood
loss during surgery was minimised, and animals found to have significant acid-base
disturbance on ABG sampling at the end of the stabilisation period were excluded from
further study. Examination of the BAL fluid of 3 haemorrhaged animals compared to 3
controls (surgery but no haemorrhage) revealed significant differences in measures of
pulmonary inflammation, alveolar air-blood barrier integrity and alveolar epithelial cell
injury (figure 8). Cell counts showed a similar total number of cells in the lavage fluid
from haemorrhaged and control animals (86.2 v.v 97.3 xl04cells/ml respectively) (figure
38B). Differential counts, however revealed a significantly larger proportion of
neutrophils in the BAL from haemorrhaged animals (12.7% vs <1%, p<0.05), with no
significant difference in the proportion of macrophages or 'other' cell types between the
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two groups. Quantification of epithelial cell type-specific integral membrane proteins in
BAL fluid showed significantly more RTI^ protein after haemorrhage (14.6 RDU vs
108.0 RDU, p<0.05), and an increase in MMC4 protein compared to controls though
this did not reach statistical significance (63.3 RDU vs 124.7 RDU, p=0.16) (figure
38C and D). The presence of alveolar epithelial injury in the haemorrhaged animals
was also confirmed by the retrieval of significantly more protein in the BAL fluid of




This study has successfully used an immunotargeting approach to obtaining information
about the phenotypes of lung alveolar epithelial cells in primary cell culture, after injury
and in development.
In order to gather information about local repair processes at the alveolar epithelium it
is not possible to rely on 'global' measures of tissue biochemistry. Using Laser
Scanning Confocal Microscopy I have developed a system to extract quantitative data
about epithelial cell populations as well as qualitative information about antigen
expression on novel intermediate cell phenotypes.
After evaluating the available methodologies, a robust and reproducible primary rat
ATII cell culture system was implemented, allowing investigation of cultured ATII cells
under controlled conditions. Immortalised transformed cell-lines were unlikely to be
adequate for this task given that the in vitro biological feature of interest is the
transformation in phenotype of ATII cells in culture.
In order to translate between the in vitro and in vivo settings this study employed a
clinically authentic disease model of bacterial pneumonia and has attempted to
generalise the cell culture and animal model findings by examining the lung alveolar
epithelium in development, seeking common features.
Imaging the lung alveolar epithelium.
Determining cell phenotype: Investigation of alveolar epithelial cell phenotype after S.
aureus induced lung injury presents particular problems. By 3 days after bacterial
instillation injured lungs are inflamed, the alveolar septae thickened and cellular. The
air spaces themselves become filled with inflammatory cells, oedema fluid and other
debris. Light microscopy allows a useful survey of the gross histology of the lung
parenchyma, but provides too little information to be relied upon to discriminate
between cell types (figure 14). Electron microscopy is information rich, but will only
provide morphological data about a very small sample of tissue, with no straightforward
additional means of characterising cells (figure 24). Immunohistochemistry provides a
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useful tool for phenotyping cells - providing that antibodies to appropriate cell-specific
markers are available (Funkhouser and Peterson 1989). In this study I have employed a
novel combination of antibodies to proteins specific to ATI and ATII cells in the
alveolar epithelium (table 4). MMC4 (anti-aminopeptidase-N) and anti-RTII70 are both
monoclonal antibodies that are, in the context of the rat lung alveolus, specific to ATII
cell membrane proteins (ref Boylan 2001, Dobbs, Pian 1997). The monoclonal antibody
anti-RTI^ is also specific to the apical cell membrane, though only in ATI cells. This
cell membrane specificity is particularly useful after injury, where antibodies to other
ATII cell specific proteins that are not membrane associated can be much less
informative for the following reasons:
1. Loss of specificity after injury: Antibodies against ATII cell specific proteins
SP-D and pro-SP-C were also used in this study to phenotype lung epithelial
cells. In control lungs, staining was neatly confined to the cytoplasm of ATII
cells as expected, and provided corroboration of the specificity of the other ATII
cell antibodies (figure 9, figure 9). After injury, however, the picture was much
less clear. The lung parenchymal changes after injury and during repair remove
a lot of the morphological cues for the identification of cells. ATII cells are no
longer confined to the 'corners' of the alveoli flanked by ATI, and alveolar
septae no longer consist of only the attenuated cytoplasmic processes of ATI
cells. The thickened, cellular alveolar walls in the repairing lung stain much less
crisply for cytoplasmic markers, with more 'background' staining, and some
weak staining of inflammatory cells with anti-pro-SPC and anti-SPD (figure
17). There are a number of possible reasons for this apparent loss of specificity;
inflammatory cells may express surfactant proteins when activated - SP-D is
known to be an opsonin and may be present on the surfaces of alveolar
macrophages in areas of inflammation. Increased surfactant secretion or loss of
surfactant from damaged ATII cells may contribute to the smearing of the pro-
SP-C and SP-D signals after injury. In contrast to the situation with cytoplasmic
markers, the antibodies to membrane associated proteins continued to provide
useful information about the phenotype of cells at the alveolar epithelial surface
after injury - though also appeared to stain some inflammatory cells in the
alveolar airspaces (figure 17, figure 15, figure 18).
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2. Sectioning artifact: Cytoplasmic stains are much more vulnerable to the
problems of sectioning - whether the physical sectioning of tissue using a
cryostat or optical sectioning with the LSCM - because the cytoplasm is not
stained uniformly, a positively stained cell can appear negative if cut and imaged
through an area containing no antigen. Membrane staining is affected by this
problem to a much lesser extent (figure 4).
3. Colocalisation difficulties: Determining whether an area of cytoplasmic
staining and apparently corresponding section of stained epithelial membrane
belong to the same cell is relatively straightforward in control lung alveolar
epithelium, but much less reliable in the injured and inflamed lung (figure 9,
figure 10 compared with figure 17). (Figure 24) shows that after S. aureus
injury ATI cells may overlie cuboidal cells. Given both the thinness of the ATI
cell cytoplasm (approximately 0.2//m) and the tendency of ATI cells overlay
ATII cells in repairing lungs (Faulkner and Esterly 1971; Greenberg, Gyorkey et
al. 1971; Evans, Stephens et al. 1972) it is unlikely that the co-expression of
cell-type specific membrane and cytoplasmic markers will discriminate between
co-expression and overlay.
The combination of ATI cell specific marker anti-RTI^ and the ATII cell specific
markers MMC4 and anti-RTII70 were the most useful for examining alveolar epithelium
in both control and injured lungs. This group of membrane staining antibodies then
defined the scope of the other markers available: MMC4 will only stain frozen lung
sections fixed in paraformaldehyde. Other epithelial cell markers I attempted to add to
the panel of antibodies (e.g. anti-Aquaporin-5 and surfactant protein A) would not stain
tissue or cells fixed with paraformaldehyde, and could not therefore be used to
investigate colocalisation with MMC4.
Demonstration of staining pattern in control lungs
Imaging control lungs stained with the panel of antibodies described above showed the
expected colocalisation of ATII cell markers MMC4, RTII70, pro-SP-C and SPD to
ATII cells, and RTI40 to the apical membrane of ATI cells (figure 8, figure 10, figure 9,
figure 37). Imaging control lung in 3D also demonstrated the structure of the alveolar
surface in a manner consistent with other published findings using from scanning
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electron microscopy (figure 3), (Fehrenbach 2001).
Quantification of epithelial staining
In order to allow quantitative as well as qualitative assessment of the alveolar
epithelium I developed a method of imaging large areas of frozen tissue sections, or
cells growing in primary cell culture, using immunofluorescence and LSCM, and then
analysing the images obtained. Images were captured and the areas of positive staining
measured as described in Methods. The simplicity of the path-tracing technique
employed allows a simple comparison of the areas covered by cells of a given
phenotype in different lung tissue sections. Comparing the figures obtained for the
relative alveolar epithelial surface area covered by ATI and ATII cells in control tissue
with those obtained from conventional morphometric analysis of the lung parenchyma
gives good agreement. Haies et al. (Haies, Gil et al. 1981) found that ATI cells occupied
97.5% of the alveolar surface leaving 2.5% for ATII cells, a surface area ratio of 39:1.
Analysis of the relative areas occupied by ATII and ATI cell luminal surfaces using the
imaging system employed in this study gives a ratio of 40:1. The literature describing
methods of extracting more complex morphometric information from 2D images
(usually electron micrographs) is substantial (reviewed in (Cruz-Orive and Weibel
1990)). In this study my aim was not to quantify the numbers or surface area of a
particular cell type in the whole lung, or even the entire inflamed portion of the injured
lung. Rather, quantification was used to compare the composition of the largely
homogeneous control lung alveolar epithelium with the repair process in small local
areas of epithelium after a very patchy lung injury. Given the strengths of our approach,
however, it would be straightforward to employ the same imaging and measuring
techniques, coupled with an appropriate sampling methodology, as the basis for more
complex morphometric studies of the lung.
Demonstration of lung inflammation and injury caused by S. aureus and S.
pneumoniae
S. aureus instillation into the distal airways induces a localized inflammatory reaction
that is resolving by 72 hours (McElroy, Cain et al. 2002). We analyzed the alveolar
epithelium in the inflamed region using membrane protein markers of ATII and ATI
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phenotype, combined with LSCM and image analysis (Dobbs, Williams et al. 1988;
Dobbs, Pian et al. 1997; Boylan, Pryde et al. 2001). The data presented here indicate
that S. awrews-inoculation leads to a focal increase in the numbers of ATII cells and a
corresponding decrease in the surface area covered by ATI cells in comparison with
control lungs. Ultrastructural studies confirmed the decrease in ATI cell numbers, or
surface area, in inflamed regions of S. aureus-injured lungs (figure 24). However, the
increase in ATII cell numbers (as indicated by ATII cell membrane-protein staining)
was not reflected in the biochemical analysis of inflamed lung for surfactant proteins
(see below).
In alveolar regions associated with increased area covered by ATII cells, I detected
alveolar epithelial membranes in which the ATI and ATII cell proteins were co-
expressed in unique combinations. The most abundant mixed phenotype were
membranes that co-expressed RTI40 and MMC4. Moreover, RTI4(/MMC4-positive cells
appeared to define a group of cells that were not uniformly positive for other ATII cell
markers (i.e. pro-SP-C or RTII70). Ultrastructural studies in other models of lung injury
demonstrate that intermediate cell types are a heterogeneous group with variable ATII-
or ATI-like characteristics (Adamson and Bowden 1974; Evans, Cabral et al. 1975;
Hirai, Yamauchi et al. 1983). It is possible that RTI4(/MMC4-positive cells are the
phenotypic equivalent, or some subset, of these ultrastructural intermediate cells.
RTI40/MMC4-positive cells that also express RTII70 or pro-SP-C may represent early
intermediates. Imaging the alveolar epithelium 24 hours after S. pneumoniae instillation
using the same antibodies to cell type specific membrane proteins showed an
inflammatory infiltrate in the air spaces, and similar population of RTI40/MMC4
positive cells (figure 22). The appearance of RTI40/MMC4 positive intermediate
phenotype cells is not a phenomenon specific to S. aureus induced lung injury.
Lung tissue biochemistry
Because the injury caused by the S. aureus model of bacterial pneumonia used in this
study appears macroscopically well circumscribed, it has been possible to examine the
concentrations of ATI and ATII cell proteins in macroscopically inflamed and
macroscopically normal regions of the lungs of treated animals. These measurements
have also been compared to control lungs. Biochemical analysis of the rat lungs used in
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this study was carried out in collaboration with Christine Tyrrell using standard
methodology (Clegg, Tyrrell et al. 2005)
Macroscopically damaged lobes (greyish areas) were homogenized separately from the
macroscopically normal lobes (pink areas). Control lungs were normal in appearance
and homogenized whole. The protein concentration of homogenized lungs was
determined using a Bio-Rad Protein assay.
MMC4 and RTI40 proteins were quantified using an ELISA-based dot blot assay as
previously described (McElroy, Pittet et al. 1995; Boylan, Pryde et al. 2001).
Western Blot Analysis - Monoclonal antibodies were detected using an anti-mouse IgG
horseradish peroxoxdiase (Rockland Immunochemicals Inc., PA, USA). Polyclonal
antibodies anti-aquaporin 5 (Chemicon International), anti-pro-SP-C (Beers, Kim et al.
1994) and anti-SP-D (Cao, Tao et al. 2004) were detected with anti-rabbit IgG
horseradish peroxidase (Rockland Immunochemicals Inc.). The optical density of
Western blot bands was determined in the usual way using a gel documentation and
analysis system.
Biochemistry - ATI cell markers:
The concentration of RTI^ was decreased by over 18-fold in the inflamed region of S.
aureus-inoculated lungs in comparison with control lungs as assessed in an ELISA-
based dot-blot and by Western blot analysis (figure 38A). Similarly, the concentration
of aquaporin 5, expressed by ATI cells and non-ciliated bronchiolar epithelial cells
(Nielsen, King et al. 1997), was decreased by 5-fold in S. aureus-inoculated lungs
(inflamed region) in comparison with control lungs (figure 38A). However, RTI^ was
not significantly different from control values, while aquaporin 5 was upregulated, in
lung tissue from the macroscopically normal regions from S. aureus-treated rats. In
combination with the morphologic data, these biochemical data suggest that the
reduction in ATI cell numbers or surface area is restricted to the macroscopically
inflamed regions of S. aureus-treated lungs.
Biochemistry - ATII cell markers
In macroscopically inflamed regions from S. aureus-treated rats, only the concentration
of MMC4 was selectively increased in the lung homogenates (figure 38B) though this
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result must be interpreted cautiously in the light of the staining of inflammatory cells
with MMC4 observable with LSCM (figure 15, figure 17). The concentration of SP-D
was significantly elevated, in comparison to control values, in both the inflamed and
non-inflamed lung homogenates in S. aureus-treated lungs while the concentration of
pro-SP-C was not significantly different in the three groups. Therefore the increased
ATII cell numbers, as indicated by an increase in the surface area of RTII70/MMC4-
positive cells seen by immunofluorescence, was not specifically reflected in an increase
in surfactant protein concentration.
Overall, the biochemistry results are broadly consistent with the picture seen using
microscopy, but appear to give a much less detailed view. Possible reasons why
biochemical analysis does not specifically reflect the increase in ATII phenotype seen at
microscopy include:
1. Reduced surfactant synthesis: Cells with a ATII cell phenotype (as defined
using membrane associated markers MMC4 and RTII70) may have a reduced
surfactant synthesising capacity during a hyperplastic response to lung injury,
and not be represented in surfactant protein assays. This loss of surfactant
production could reflect an early stage in the process of transformation to a ATI
phenotype. (Fehrenbach, Kasper et al. 1999; Yano, Mason et al. 2000).
2. Tissue biochemistry not a sensitive enough tool: Even within a lobe of the
lung that is macroscopically inflamed, there is a huge variation in morphology at
the alveolar level (figure 14) that is simply 'averaged out' by biochemical
analysis. Examining the concentration of cell specific markers in homogenised
tissue can be likened to holding a microphone above a football stadium to hear
what the fans' are saying. It is not difficult to tell when a goal has been scored,
but the technique loses its usefulness when trying to ascertain information about
an individual supporter.
Primary ATII cell culture - in vitro corroboration of the in vivo findings
Isolation of ATII cells: In 1974 Kikkawa and Yoneda published a method for the
isolation of ATII cells, to facilitate the investigation of surfactant biochemistry. Since
then it has become possible to isolate ATII cells from a variety of species to facilitate
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the investigation of epithelial cell biology (reviewed in (Dobbs 1990)) (Kikkawa and
Smith 1983; Richards, Davies et al. 1987; Murphy, Dinsdale et al. 1999). Methods of
ATII cell isolation can be placed into two broad categories, defined by the technique
used to separate ATII cells from the initial cell suspension obtained by mechanical
disruption and enzymatic digestion of the lung parenchyma.
I initially used the discontinuous density gradient technique described by Richards et al
(Richards, Davies et al. 1987). The lung vasculature is first perfused to remove blood,
this is then followed by repeated broncho-alveolar lavage to wash out alveolar
macrophages. The lungs are then digested using proteolytic enzymes to free ATII cells.
The technique described by Richards uses trypsin to achieve this, which was added to
minced lung tissue. DNAase is also added to reduce cell clumping. In order to separate
ATII cells from other contaminating lung cells the principle of differential
sedimentation was used by centrifuging the filtered crude cell suspension in a tube
containing a discontinuous Percoll gradient. The sedimentation velocity of a cell is
proportional to its density and the square of the cell diameter (Boone, Harell et al.
1968), which causes cells of similar size and density to accumulate in a band at the
same level within the centrifugation tube. The fundamental problem with this method is
that ATII cells overlap with other lung cell types in size and shape. In order to obtain a
relatively pure sample of ATII cells it is therefore necessary to reject a significant
proportion of the ATII yield along with contaminant cells. The resulting subset of ATII
cells may be less than 10% of the total number in the lungs and therefore may not be
representative of the rest of the ATII population (Dobbs 1990).
Because of the problem of obtaining large enough numbers of sufficiently pure ATII
cells I abandoned this differential sedimentation approach in favour of the differential
adherence based method favoured by Dobbs (Dobbs 1990) (see Materials and Methods
section above). Dobbs' method is very similar to Richards' in the initial stages, though
enzyme digestion is accomplished by instilling intra-tracheal elastase rather than adding
trypsin to minced tissue. The crude cell suspension obtained contains mainly
macrophages and leukocytes as contaminants, which are removed by 'panning' the
mixture over culture plates coated with non-specific rat Immunoglobulin G (IgG). By
binding to the IgG via the leukocyte common antigen or to Fc receptors, the majority of
macrophages and leukocytes can be removed leaving ATII cells in suspension. This
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method improved the yield and purity of ATII cells obtained.
Examination of ATII cells in culture: The phenotype of isolated ATII cells as they
transform to ATI-like cells confirmed the presence of MMC4/RTI40 positive cells at a
time point in culture before epithelial cells were defined as ATI-like cells (i.e. RTI40-
positive attenuated cells) (figure 30, figure 29). Importantly, the presence of
MMC4/RTI40-positive cells in culture also demonstrated that co-expression was not a
specific response to bacterial pneumonia but more likely to be generalized to alveolar
epithelial repair. It is not known whether MMC4 co-expression with RTI40 has any
functional significance or whether co-expression reflects the possibility that the MMC4
protein has a longer half-life than other ATII cell-selective proteins.
3D imaging of MMC4/RTI4Q positive cells showed the concentration of RTI40 at the
spreading edge of flattening cells (figure 30). The function of RTI40 is not known,
though data from RTI40 null mice suggest that it is required for ATI cell differentiation,
and normal alveolar development. Mice lacking RTI^ die at birth from respiratory
failure, and are found to have lung markedly abnormal lung histology, with thickened
alveolar septae and tortuous alveolar lumens (Ramirez, Millien et al. 2003). The study
of RTI^ in other systems sheds some light on possible functions in the lung. Scholl et al
found that RTI^, (PA2.26) is associated with the organisation of the actin cytoskeleton
and migration in cultured keratinocytes, concentrating in actin rich vili, filopodia,
lamellipodia and ruffles (Scholl, Gamallo et al. 1999). Similarly, in cultured lymphatic
endothelial cells, over expression of RTI40 enhanced cell migration and filopodia
formation (Schacht, Ramirez et al. 2003). It seems likely that RTI40 has an important
role in facilitating the flattening, spreading and migration of differentiating intermediate
cells.
Development
Immunofluorescence and imaging using the LSCM were used to ascertain whether
MMC4/RTI40 intermediate cells are part of the process of rat lung development. RTI40
has been detected in the foetal rat lung as early as embryonic day 15 (E15), but is not
easily detectable until E17 becoming more abundant thereafter (Williams and Dobbs
1990). I was able to detect RTI40 in the central nervous system of the foetus at E16 as
previously described (Williams, Cao et al. 1996), but did not see lung expression until
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E17 (figure 31, figure 32). The MMC4 antigen was detected at El6 by Boylan et al.
using ELISA based dot-blot, but immunofluorescence was not attempted in this study
until E21 (Boylan, Pryde et al. 2001). Lung staining with MMC4 was not detectable in
this study by immunofluorescence at E16 or E17 (figure 31, figure 32), but was present
at E20, colocalised on ATII cells with RTII70 (figure 33). Although morphologically
intermediate cells have been described in foetal sheep (Flecknoe, Wallace et al. 2003),
and cells colocalising ATI (RTI40) and ATII (MPA) specific markers in foetal rats
(Williams and Dobbs 1990) I did not detect cells with a RTI^/MMCd phenotype in the
foetal rat lung. Lungs were examined postnatally, however, as extensive alveolar
remodelling occurs in rat pups - as evidenced biochemically by continued changes in
RTI40 and MMC4 protein concentrations (Boylan, Pryde et al. 2001). No intermediate
phenotype cells were seen in the alveolar epithelium at postnatal days 3, 4 or 5 (figure
34, figure 35). At post-natal day 3 (PN3), RTI40/MMC4 positive cells were seen in the
epithelium of the terminal bronchiole, with occasional epithelial cells expressing RTII70
in addition to RTI40/MMC4 at the broncho-alveolar junction (figure 34). The
significance of this finding is unclear, although the epithelium of the terminal
bronchiole is known to contain a variety of progenitor cell-types (Giangreco, Reynolds
et al. 2002; Hong, Reynolds et al. 2004).
A current scheme for epithelial repair
It is likely that in the normal adult lung the vast majority of cells exist in a quiescent
state (i.e. G0) (figure IB a.). (Uhal 1997). After injury the progenitor ATII cell is
somehow stimulated to divide, enters S phase and then undergoes mitosis leading to
relatively undifferentiated cuboidal daughter cells, possessing some ATII cell
characteristics (e.g. microvilli), but lacking others (e.g. lamellar bodies) (figure IB b.).
Morphological intermediates consistent with this suggestion have been observed in
models of alveolar epithelial injury, including (Adamson and Bowden 1974) and
(Evans, Cabral et al. 1975). In our S. aureus pneumonia model, these cells appear as
MMC4/RTII70 positive - still having a ATII cell immunophenotype, but occurring
contiguously along the alveolar epithelium, and covering a much greater area than in
control lungs. These cells may represent what Hirai et al describes as 'early
intermediates' (Hirai, Yamauchi et al. 1983). Daughter cells may then assume a ATI or
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ATII cell phenotype. As they differentiate towards the ATI phenotype early
intermediate cells are likely to shed ATII phenotypic markers (figure IB c.). The
finding that in the S. aureus injured lungs some MMC4/RTII70 cells are pro-SP-C
negative is consistent with this, but may also simply represent the down regulation of
surfactant synthesis after injury induced hyperplasia (Fehrenbach, Kasper et al. 1999;
Yano, Mason et al. 2000). RTI40/MMC4 positive cells (figure IB d.) can be described
as Tate intermediates' (Hirai, Yamauchi et al. 1983). Expression of RTI40 by
intermediate cells may facilitate migration and spreading as part of epithelial repair,
RTI40/MMC4 positive cells in our culture system become flattened and attenuated
consistent with this suggestion. Finally, the intermediate becomes a fully differentiated
ATI-cell, losing MMC4 expression (figure IB e.).
The ATI cell has often been regarded as terminally differentiated, but evidence exists
that foetal ATI cells (Flecknoe, Wallace et al. 2002) and ATI-like cells in culture
(Shannon, Jennings et al. 1992) can be induced to transdifferentiate to a ATII cell
phenotype, though this phenomenon has not been demonstrated experimentally in an
adult lung. In addition, it seems from the weight of evidence derived largely from in
vivo stathmokinetic studies (i.e. induction of metaphase arrest) that only the ATII cell
phenotype is able to re-enter the cell cycle for further division (Adamson and Bowden
1974; Evans, Cabral et al. 1975).
After a more severe injury to the alveolar epithelium, it is possible that progenitors from
the terminal bronchioles or even circulating bone marrow derived cells contribute to
repair (figure IB f.).
Alveolar epithelial repair in the context of other tissues
Consideration of the process of healing in other tissues offers a framework with which
to consider factors affecting the repair process in the alveolar epithelium. Generic
mechanisms of tissue repair are usefully summarised by Mutsaers et al. who offer a
summary of the 'highly orchestrated sequence of events' (Mutsaers, Bishop et al. 1997).
This complex multistage process involves several overlapping stages that occur broadly
sequentially. Initially haemostasis is achieved by platelet aggregation, clot formation
and local vasoconstriction. This is followed by hyperaemia and increased permeability
of nearby blood vessels facilitating an inflammatory infiltrate. Provisional matrix
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composed largely of fibrin, fibronectin provides a scaffold for the inflammatory
process, becoming granulation tissue as fibroblasts lay down matrix in which new
vessels are forming. Remodelling by the rapid synthesis and degradation of connective
tissue proteins leads to scar formation initially as production exceeds removal. The final
phase of the normal repair process involves resolution of scar tissue.
Mutsaers details the important categories of interactions involved in the coordination of
wound healing (Mutsaers, Bishop et al. 1997):
1. Cell-cell and cell-matrix interactions: These interactions trigger migration, growth
and differentiation and can be categorised as cell-matrix adhesion interactions at the cell
basal surface (e.g. integrins and their ligands), cell-cell interactions between adjacent
cells (e.g. cadherins, intercellular adhesion molecules), and luminal cell-cell adhesion
molecules (e.g. platelet-endothelial cell adhesion molecule, granule-associated
membrane protein 140).
2. Extracellular Matrix (ECM) Turnover: In addition to the action of matrix
components via integrins ECM can also bind and later present other bioactive factors.
Fibroblasts are involved not only in the synthesis of ECM components, but also in their
degradation by production of enzymes such as matrix metalloproteinases (MMPs).
Regulation of the balance of these processes is by a variety of mechanisms (autocrine,
paracrine and endocrine).
Key mediators of wound healing and fibrosis are also identified as locally released
peptide growth factors and cytokines (e.g. platelet derived growth factor (PDGF),
transforming growth factor beta (TGF-[)), fibroblast growth factor (FGF), epidermal
growth factor (EGF)), blood-derived proteins (e.g. fibrinogen and fibronectin), and the
mechanical environment.
Healing in the lung - avenues for further work
In the context of the lung, the pathological process in ALI/ARDS has been similarly
characterised as a series of stereotypical stages that reflect the failure of normal repair
and resolution (see earlier: page 16). Detailed morphological and morphometric studies
as early as the 1970s characterised the generic response of the lung to injury (Bachofen
and Weibel 1974). Bachofen and Weibel carefully describe the appearances under the
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electron microscope of human lung tissue with established ARDS fixed within 30
minutes of the patients' death. The 'basic feature' common to all of the injured lungs
examined was the 'transformation of alveolar epithelium into a cuboidal epithelial
lining, together with interstitial oedema and a proliferative reaction of the connective
tissue...". This connective tissue proliferation led to lung fibrosis, worsening gas
exchange and death after a disease duration of between 21 and 60 days in the patients
studied (Bachofen and Weibel 1974). Recent examination of the onset of the
fibroproliferative response after acute lung injury has shown some unexpected results.
In contrast to the traditional characterisation of the pathogenesis ARDS where fibrosis
is a late event in the disease process, Marshall et al. have found evidence of
fibroproliferation after 24 hours, implying that fibrosis begins in parallel with initial
exudative and inflammatory events (Marshall, Bellingan et al. 2000). Many of the
factors which are highlighted as important modulators of tissue repair in other organ
systems have been examined in the context of lung injury and suggest avenues of
investigation for future work:
1. Integrin and matrix interactions: White et al. examined monolayer wound repair in
a series of studies using a cultured human non-secretory central airway epithelial cell
line (16HBE14o). Monolayers were grown on a variety of ECMs (collagen-IV, laminin-
1, or laminin-2 matrix) and wounded. Wound closure was blocked by monoclonal
antibodies to (31 -integrin or agglutinins preventing the binding of alpha-dystroglycan to
laminin indicating that these interactions are required for airway epithelial cell
spreading and migration (refs) (White, Dorscheid et al. 1999; White, Wojcik et al.
2001). The [36-integrin subunit has also been implicated as important in distal airway
epithelial repair and resolution of inflammation (Breuss, Gallo et al. 1995; Huang, Wu
et al. 1998). It would be potentially very useful to delineate the effect of disruption of
these integrin/matrix interactions on the transdifferentiation of ATII cells during
alveolar epithelial repair.
2. Mechanical environment: It is clear that the lung is very sensitive to mechanical
stress, particularly that induced by positive pressure ventilation in the context of lung
injury. The adverse effects of non-physiological mechanical distension on the lung have
been demonstrated cell culture, animal models and in clinical studies, with a variety of
putative mechanisms cited for these findings (Lecuona, Saldias et al. 1999; Vlahakis
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and Hubmayr 2000; Matthay, Bhattacharya et al. 2002; Gajic, Lee et al. 2003; Vlahakis
and Hubmayr 2005) (2000). Stretch modulates the proportion of ATII cells in the lung
alveolar epithelium during both development and maturation of the lung and following
lung injury and has been shown to affect the ATII to ATI cell transdifferentiation
process studied in this thesis directly (Gutierrez, Gonzalez et al. 1998), (Stuart
McKechnie unpublished data). Translating these findings into the clinical context, it
would be useful to examine the effect of positive pressure ventilation on the alveolar
epithelium in the context of injury. The so-called 'two-hit' model reflects the clinical
reality for many critically ill patients. Both hypoxia (Vuichard, Ganter et al. 2005) and
resuscitated haemorrhagic shock (Fan, Marshall et al. 1998) have been shown to 'prime'
rodent lungs leading to a greater severity of injury when exposed to a 'second hit' (in
these studies LPS induced ALI). It is likely that mechanical ventilation will act
synergistically with other pathological insults to damage the lung in the context of
illness/injury and resuscitation. It would be profitable to elucidate the mechanisms for
this and find ways of ameliorating the effect since no practicable alternative to positive
pressure ventilation is currently available to the critically ill patient requiring ventilatory
support.
Summary
This work has shown that characterized ATI and ATII cell membrane markers can be
used to identify and quantify the alveolar surface area covered by ATI and ATII cells at
localized regions of repair following lung injury. Some cells in repairing alveolar
epithelium co-express ATI and ATII cell markers, not seen in other regions of the
inoculated lung or control lungs. Our data suggest that RTI40/MMC4-positive cells are
intermediates in the ATII to ATI cell transition, this is further corroborated by the
appearance of RTI40/MMC4 positive cells during the transformation of ATII cells to
ATI-like cell in vitro. This is the first study to identify alveolar epithelial intermediate
cells based on the expression of membrane protein markers. It is not possible in the lung
to easily determine the progeny relationships because cells can migrate in three
dimensions. Markers that define the phenotype of epithelial cells in transition represent
a unique method to address fundamental issues regarding the role and regulation of
ATII cell transdifferentiation in different models of lung injury including fibrosis.
Page 76
Unravelling the process of lung alveolar epithelial repair is crucial to understanding a
wide range of lung pathologies, from acute lung injury to chronic fibrosis. The ATII cell
appears to have a central role in this, though the factors that modulate its proliferation
and differentiation in vivo remain obscure. It would be informative to compare the
effects of indirect lung injury (e.g. haemorrhagic shock) with the repair process after the
direct injury used in this study. A more homogeneous lung injury may facilitate
investigation into the effects of a clinically relevant 'second-hit' (like hypoxia or the





A: The model circa 1980'
B: A current model
c. MMC4/RTII70 positive,
pro-SP-C negative?
(A) In this model the ATII cell is the progenitor of ATI and ATM cell types. Division of an ATM cell porduces daughter
cells, one of which becomes a terminally differentiated ATI, the other retains the ATII phenotype and replenishes
the ATII cell population. (B) Here, the ATII cell is the usual progenitor of ATI and ATII cell types. Cell division gives
rise to two undifferentiated daughter cells that can assume either ATI or ATII cell mature phenotype.Transforma-
tion from ATII cell to ATI cell phenotype is potentially reversible, but only ATII cells can re-enter the cell cycle. After
severe epithelail injury, cells from outside the alveolus may contribute to repair. Adapted from Uhal (1997).
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figure 2
A: simplified optics of a laser scanning confocal microscope (LSCM)
in focus light
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figure 3
Tissue blocks approximately 5mm3 stained with anti-RTI40 (green 488), MMC4 (red 546) and RTII70 (blue 647). The three
dimensional structure of the alveolus is clearly visible in the tissue blocks (A) and (B) with the purple MMC4/RTII70 positive
apical membranes of ATII cells protruding from the RTI40 positive ATI cells lining the alveolar airspace (Aa). Selecting single
optical sections (C) and (D) from the 3D stacks reveals the internal structure of the tissue - the familiar 2D appearance of
RTUo positive ATI cell 'tram lines'flanking ATII cells.
For comparison, (E) shows a scanning electron micrograph of human lung taken from Fehrenbach (2001).Two ATII cells (P2)
protrude above the largely smooth alveolar epithelial surface. A pore of Kohn (K) and the cell-cell junction (arrowheads)
between two ATI cells are indicated.









Rats are maintained in a vertical position by suspension on a horizontal wire by the front upper incisors (A).The intubation
wedge is placed in the mouth and tracheal tube inserted (B-D). Bacterial suspension or PBS control is instilled resulting in
a reproducible left lower lobe pneumonia (E, F). (E) and (F) adapted from Bakker-Woudenberg IA (2003) Experimental
models ofpulmonary infection. J Microbiol Methods 54(3):295-313
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figure 5

















































detected as 'red'Alexa 546 if
single track scanning employed.
375 425 475 525 575 625 675 725
Excitation/Emission Wavelength (nm)
775
Diagram shows (A) the emission spectra of the Alexa secondary antibodies used for staining. Alexa 647 emissions were
filtered through a Low Pass 650nm filter, Alexa 488 emissions through a Band Pass 500-530nm filter, and Alexa 546
emissions through a Band Pass 565-615 filter. (B) The excitation spectra for the red and green flourophores overlap. If they
are detected simultaneously, then the tail of the green emission may be erroneously recorded as red (red shaded area).










Quantification of an image of a control lung section otained by confocal microscopy. The area of interest (e.g. the MMC4
(red 546) positive ATM apical membrane) is highlighted by creating a binary map of the areas of positive fluorescence
staining. Here a white map has been created for the MMC4 positive areas and overlaid on the original image (B). The the
lengths of the regions of interest are then traced using a graphics tablet, after image calibration (D).The lengths obtained
in this way can be expressed as a fraction of the entire epithelial surface in the image, by tracing the whole epithelium (C).















Internal Carotid artery cannulation:
for invasive blood pressure
measurement, ABG sampling and
venesection.
Jugular venous cannulation: for
drug and resuscitation fluid
administration and venous sampling.
Tracheostomy: to facilitate
mechanical ventilation.
Monitoring: rectal temperature, heart
rate, invasive blood pressure, oxygen
saturations.
Haemorrhage: withfrawl of blood
over 10-15 mns to maintain MAP of
40mmHg (i.e. removal of -35%
circulating volume).
Infusion of warmed normal saline
through central venous cannula to
maintian MAP of 80mmHg
Retrieval of bronchoalveolar lavage






























A: Diagram showing the prcedure for the rat model of haemorrhagic shock.
B: The invasive mean arterial pressure trace from a representative experiment.
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figure 8
Control lung stained with MMC4 (546 red), RTI40 (488 green), and RTII70 (647 blue). Alveolar airspaces (Aa) are lined by RTI40
positive ATI cells with MMC4/RTII70 positive ATII cells (short broad arrow) in the corners of the alveoli. A blood vessel (Bv) is
also visble in the low magnification view (A). A high magnification view of terminal bronchiolar epithelium (B, inset) shows
MMC4 positive/RTII70 negative Clara cells (arrowheads).
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figure 9
Control lung stained with anti-RTI40 (647 blue), MMC4 (546 red), anti-pro-SP-C (488 green) and DNA dye TO-PRO-3 (647
blue). RTI40 positive ATI cells form most of the alveolar wall (double arrows) with ATII cells (broad arrow) at the corners of
the alveoli. ATII cells stain with MMC4 at the apical membrane and anti-pro-SP-C in the cytoplasm.
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figure 10
Control rat lung stained with anti-SP-D (green 488), anti-RTI40 (blue 647), and MMC4 (red 546). RTI40 positive ATI cells line
the alveolar airspaces (Aa). ATM cells are easily identifiable by their MMC4 positive apical membranes (arrowheads). The
cytoplasm of ATM cells also stains strongly positive for SP-D. Some alveolar macrophages also stain weakly positive for
SP-D (white arrows).








Control lung stained with anti-RTI40 (green 488), MMC4 (red 546), and anti RTII70-(blue 647). The image shows a ATI cell
sectioned en face (ATI) surrounding a ATII cell (broad arrow). Images (A) and (B) are taken in different vertical planes,from
the top and bottom of the section. The MMC4/RTII70 positive apical membrane of the ATII cell is clearly visible in (A), but
disappears almost completely in B. The 3D reconstruction in (D) shows the actual positions of the cells relative to one
another.







Control lung stained with anti-RTI40 (green 488), MMC4 (red 546), and anti RTII70 (blue 647).The image shows a
ATI cell sectioned en face (ATI) surrounding a ATM cell (broad arrow). The 3D reconstruction of a stack of optical
sections can be interrogated to show the top (A), botttom (C) or section through the specimen (B).
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figure 13
merged: MMC4+RTII70+RTI40+To-PrO;3
Schematic (D) shows the consequences of imaging a thin optical section through a thin but uneven specimen.
Only the portion of the image to the left of the field of view is in focus (and therefore brighter) when scanning at
plane z1 (A), whereas the right of the field is best seen at z2 (B). Combining images taken at both planes includes
all of the information on the section, green and red channels (RTI40 and MMC4 staining respectively) illustrate the
point above.Combining layers (C) allows all of the cells present to be seen.
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figure 14
A
The morphology of rat lung sections demonstrated on haematoxylin and eosin stained paraffin-fixed sections. Control
lung section (A) shows alveolar air spaces (asterisks), blood vessels filled with red cells (Bv), and a terminal bronchiole (Br).
(B) shows an area of consolidation in which the small airspaces are filled with cells and debris (asterisks). In some areas
the alveolar wall is not distinct from the airspaces or the inflammatory cell influx (white asterisk). (C) shows the boundary
(arrows) between obviously inflamed tissue with thickened alveolar walls and inflammatory cells in the airspaces (Inf)
and a region which is morphologically indistinguishable from control lung (Norm).Bar=100pm.























Inflamed rat lung sections stained with MMC4 (red 546), RTI40 (green 488) and RTN70 (blue 647). Images demonstrate that
the surface area of alveolar walls co-expressing the ATM cell markers MMC4/RTII70 is increased in comparison to control
lungs (purple cells, small arrowheads). While the alveolar surface covered by the ATI cell marker, RTI40 is decreased in
comparison to control lungs (green, broad arrow). Some alveolar membranes are stained with a new combination of
MMC4 (red) and RTI40 (green) to generate yellow membranes (inset magnified in (D) longer arrow indicates MMC4/RTI40
positive area). Image also demonstrates that monocytes/macrophages in the airspaces express MMC4 (asterisks).
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figure 16
Ctrl Inf Ctrl Inf Ctrl Inf
Percentage of the alveolar wall covered by ATI and ATII cell-markers in S.aureus-injured (n=3) and control (n=5)
lungs. Images captured and analyzed as detailed in Methods.The total epithelial surface measured in control
and S. aureus-treated lungs was 16,063 ± 3,058 pm and 15,783 ± 1,203 pm, respectively. A: ATI cells (RTI40
positive membranes), B: ATII cells (RTII70/MMC4-coexpressing membranes). C: Alveolar Intermediate cells
(RTI40/MMC4-coexpressing membranes). (Error bars show SEM).
D: Measured length of RTI40/MMC4 positive membrane
pm
<1 ATII mean apical
membrane length
D: Frequency histogram shows the distribution of the measured lengths of alveolar epithelium that co-
expressed MMC4 and RTI40 in control lungs (n=5),and inflamed lungs (3 days post injury, n=3). Almost all of the
segments of epithelial surface expressing MMC4/RTI40 in the control lung were less than the mean apical mem¬
brane length for a ATII cell (i.e. < 7pm). In contrast to this, most of the MMC4/RTI40 expressing areas in repairing
lung were more than one cell in length - the majority being more than 7pm long. (Error bars show SEM).
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figure 17
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Inflamed rat lung day 3 after infection is stained with MMC4 (red 546), anti-RTI40 (blue 647) and anti-pro-SP-C (green 488)
or anti-SP-D (green 488). Alveolar walls are lined by RTI40 positive cells double arrows, and MMC4 positive cells (broad
arrows). Cells with MMC4 positive apical membrane do not universally stain positive for pro-SP-C or SP-D. MMC4/RTI40
positive cells are also visible in (A) which do not consistently stain positive for pro-SP-C (inset in (A) and separations - single
arrowheads).





















Repairing rat lung alveolar epithelium 3 days after injury stained with MMC4 (red 546), and RTI40 (blue 647). In (A) Most of
the epithelial surface is RTI40 positive (double arrows), but a significant proportion is MMC4 positive (broad arrows). Some
areas are MMC4/RTI40 positive (purple staining, longer arrows). Using image analysis software, the areas colocalising
MMC4/RTI40can be identified and superimposed on the transmitted image (B). Areas of interest (i.e. not inflammatory
cells) can be isolated and the colocalisation viewed in 2D (yellow areas in (F)). Using image stacks from the LSCM, the
pattern of colocalisation through the entire depth of the section can be viewed in 3D (G). It is easily seen in (G) where
colocalisation is merely a ATI-ATM cell junction (arrowheads), and where severel cells are co-expressing RTI and MMC4 at
their apical membranes (large arrows). figure 18 of 38
figure 19
Repairing rat lung stained with MMC4 (red 546), RTI40 (green 488) and RTII70 (blue 647).The epithelium in (A) shows an area
of MMC4/RTI40 staining (broad arrow), but also other areas which are positive for both ATII markers MMC4 and RTH70 in
addition to RTI40 (arrowheads). (B) Shows an area of epithelium where several adjacent cells have a ATII cell MMC4/RTII70
phenotype (double arrows).
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figure 20
(A) and (B) show perpendicular views of a small segment of rat control lung alveolar epithelium stained with MMC4 (red
546) and RTI40 (green 488). The MMC4 positive apical membrane of a ATM cell is visible, flanked by RTI40 positive ATI cells.
After image deconvolution there is a small area of yellow where the green and yellow signal occupy the same voxel (single
arrowheads) - this represents the limits of this imaging system in resolving the junction between ATI and ATII cells.
In (C) and (D) a segment of repairing rat lung alveolar epithelium has been similarly stained, the membrane shows
colocalisation of red and green signal across the whole depth of the section (broad arrows), indicating that this area of
epithelium is uniformly expressing both MMC4and RTI40.
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figure 21
Measured length of ATII cell (MMC4/RTII70 positive) membrane














The lengths of individual segents of epithelial membrane expressing ATII cell markers MMC4and RTII?0 have been plotted
in the form of a frequency histogram for control (n=5) and inflamed (n=3) lungs. The mean value for the length of ATII celll
apical membrane is ~7pm,and the majority of control ATII cells were measured at around this length. Inflamed lungs had
a mean segment length of ~15pm,with many segments of ATII cell phenotypeepithelim which were significantly longer
than this.
figure 21 of 38
figure 22
B
Rat lung 24 hours after instillation of S pneumoniae, stained with MMC4 (red 546), RTI40 (green 488), RTII70 and DNA dye
T0-PR0-3 (blue 647). The lower power view (A) shows a significant inflammatory infiltrate in many alveolar airspaces
(asterisks). Most of the alveolar epithelium is covered by RTI40 positive ATI cells, with MMC4 positive ATII cells also visible
(NB inflammatory cells in the airspaces are also stained red with MMC4J.A population of MMC4/RTI40 positive intermediate
phenotype alveolar epithelial cells is also visible (white arrows).The higher magnification inset in (A) and seperate colour
channel images in B show an area of MMC4/RTI40 positive epithelium (arrowheads).
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figure 23
A
Long thin attenuated ATI cells characteristically showing a paucity of organelles with only the prominent nuclei evident -
(B). Cuboidal ATM are positioned in the corners of the alveoli, flanked by ATI (B) and closeup in (A). (B) also shows an endo¬
thelial cell (En) and erythrocyte (RBC) making up the other components of the alveolar air-blood barrier. The sine qua non
of ATM cells is presence of surfactant containing lamellar bodies (LB) which resemble the layers of an onion in cross-section
(C) and (D). ATII also have microvilli (Mv) at their apical surface.
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figure 24
A
Electron microscopic examination of the rat alveolar epithelium during repair. Some epithelial cells had more typical ATII
cell features lamellar bodies (LB), apical microvilli (arrowheads) but appeared to be spreading, and had reduced
perinuclear cytoplasm (A). Other cuboidal epithelial cells lacked both microvilli and lamellar bodies (B). In some places ATI
cells (or ATI-like cells) were observed overlying ATII cells (C), inset shows a high magnification view of one cell membrane
overlying another (arrows).
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figure 25
A Pap stain of ATM cell cytospin





Cytospin preparations of freshly isolated rat ATM cells (n=3) were Pap stained and differential cell counts performed. ATII
cells with characteristic lamellar bodies staining dark purple can be seen in (A) (broad arrows), contaminating lymphocytes
are also visible (arrowheads). (B) Shows the types and quantities of contaminants routinely present in the ATII cell prepara¬
tions. (Error bars show SEM).

















,40 (green 488), and anti-RTII70
, but not anti-RTI
Rat alveolar epithelial cells in primary cell culture stained with MMC4 (red 546), anti-RTI
647). Freshly isolated ATM cells are stain positively with MMC4 and anti-RTII70,
culture, the ATII cells have acquired some characteristics associated with the mature ATI cell type - they become flattened,
no longer stain with MMC4 or anti-RTII70, and are positive for anti-RTI40 (C) and (D).
(blue
40 (A) and (B). After five days in
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figure 27
A
Rat ATM cells after five days in culture stained with MMC4 (red 546),anti RTI40 (green 488) and TO-PRO-3 (blue 647). ATII in
culture at this time point have acquired some of the characteristics of mature ATI cells-they are flattened and attenuated,
with large nuclei.Cells no longer stain positively with MMC4 but are positive for RTI40,a ATI cell specific antibody. (A) Is a 3D
image of cells in culture demonstrating the change in morphology - a schematic of a freshly isolated ATII cell is drawn to
scale for comparison. (B) Shows traditional 2D immunofluoresence images showing MMC4 negative/RTI40 positive stain¬
ing.
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figure 28
A
Rat ATII cell in primary culture stained with MMC4 (red 546), anti-RTI40 (green 488) and TO-PRO-3 (blue 647). The 3D image
in (A) shows the typical cuboidal shape, (B) is a set of traditional 2D immunofluorescence images demonstrating positive
staining with the ATM-cell specific marker MMC4. The cell is negative for RTI40.


















Rat ATII cell in primary culture stained with MMC4 (red 546), RTI40 (green 488) and TO-PRO-3 (blue 647). After 1 day in
culture some cells have begun to spread and flatten, with a sub-population staining positive for both MMC4 and RTI40 (B).
3D visualisation of these cells (A) shows that RTI is localised to the periphery of the cell at the basal surface.





















Rat ATII cells in primary culture at day 1 stained with MMC4 (red 546), RTI40 (green 488),TO-PRO-3 (blue 647). Many cells
can be seen flattening and taking on a more ATI-like morphology. Some cells are beginning to stain positively for RTI40
(broad arrow). A small population of cells stains strongly for MMC4 and RTI40 (longer arrow). (B) 3D imaging of the co-
expressing cell highlighted in (A) (longer arrow) reveals that RTI40 is localised to the spreading basal surface of the cell.
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Schematic shows the gross anatomy of the developing rat at embryonic day 16/21 (E16). A parasaggital section stained
with MMC4 (red 546), RTI40 (green 488) and TO-PRO-3 (blue 647) showed positive RTI40 staining in the choroid plexus (A)
and around the spinal canal (B) at the level of the thoracic spine. No staining was seen in the embryonic lung at this stage.
(Schematic diagram redrawn using comparative information from The Atlas ofMouse Development MH Kaufman (Editor),
Academic Press 1992).
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Foetal rat lung at embryonic day 17/21 (E17) stained with MMC4 (red 546),RTI40 (green 488) and T0-PR0-3 (blue 647). (A)
Shows a 'tiled'image of several fields of view obtained using thex5 objective and includes two tissue fragments. Higher
power views in (B) & (C) show an example of the occasional tubules lined with RTI40 positive airway epithelial cells.






Foetal rat lung at embryonic day 20/21 (E20) stained with MMC4 (red 546), RTI40 (green 488), RTII70 (blue 647) and TO-PRO-3
(blue 647). Alveolar airspaces (Aa) are separated by thickened cellular septae, lined with RTI40 positive epithelial cells
(broad arrows). Putative ATM cells expressing MMC4 and RTN70 appear in clusters (long arrows). A bronchiole is visible (Br)
lined by epithelium containing many MMC4 positive, RTH70 negative Clara cells (double arrowheads).
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figure 34
A
Rat lung at post-natal day 3 stained with MMC4 (red 546), RTI40 (green 488) and RTII70 (blue 647).The alveolar airspaces are
lined by RTI40 positive cells, with cells expressing both MMC4 and RTII70 scattered throughout. MMC4/RTI40 co-expressing
cells were not seen in the alveolar epithelium, but were evident in the bronchiolar epithelium (broad arrow) along with
occasional cells around the broncho-alveolar junction which expressed MMC4/RTI40 and RTH70 (long arrows).
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figure 35
MMC4 + RTI40 + RTII70 merged tiled image
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Rat lung sectioned at postnatal days 4 (A) and 5 (B), stained with MMC4 (red 546), RTI40 (green 488) and RTII70 (blue 647).
Alveolar airspaces resemble adult lung lined predominantly by RTI40 positive ATI cells (broad arrows),with MMC4/RTII70
positive ATM cells at the corners of alveoli (arrowheads). (B) Shows the colocalisation of staining in 3D with the RTI40
positive apical membranes of ATI showing a 'tram-line'appearance (broad arrow) and the MMC4/RTII positive apical
membranes of ATM cells protruding into the alveolar air space (arrowheads).
figure 35 of 38
figure 36




































Control Haemorrhage Control Haemorrhage








































Graphs showing analysis of BAL fluid from rats undergoing haemorrhagic shock and
resuscitation (n=3), and control rats that underwent surgery but no haemorrhage (n=3).
(Error bars show SEM).
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A section of adult rat lung stained with MMC4 (red 546), RTI40 (green 488), RTII70 and T0-PR0-3 (blue 647).The tissue has
been scanned as a stack of optical sections and rendered to give a 3D image which is rotated slightly to show the depth
of the tissue section. MMC4/RTII70 positive ATII cells can be seen in the corners of the alveoli (arrowheads) which are
lined by RTI40 positive ATI cells (broad arrows).






Ctrl N-Inf Inf Ctrl N-Inf Inf Ctrl N-Inf Inf
MMC4 ProSP-C SP-D
Biochemical analysis of ATI and ATM cell-selective proteins in lung homogenates from control and S. aureus-injured lungs
(n=3).Western blots were performed and RTI40 (band at 40 kDa), Aquaporin 5 (band at 28 kDa), pro-SP-C (band at 21 kDa),
and SP-D (band at 42 kDa) were scanned and relative densitometry units are shown per mg of protein. The data for the
MMC4 protein (which does not Western blot) were derived from an ELISA-based dot blot assay.
Abbreviations - Controls (Ctrl) and S. aureus instilled lungs: non-inflamed (N-Inf) and inflamed (Inf) regions. Values signifi¬
cantly different from control values are shown (data analyzed using ANOVA). Error bars show SEM.
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Appendix A: List of solutions
Stock solutions for ATII cell isolation
Name FW Concentration Weight Volume
NaCl 58.44 9% (1 Ox stock) 45 g 500 mis
KC1 74.55 0.15M 5.6 g 500 mis
CaCl2.2H20 147 0.11 M 1-62 g 100 mis
MgSO4.7H20 246.5 0.15M 2.45 g 100 mis
Sodium 0.1M 0.275g monobasic to 1.13g 200 mis
phosphate dibasic, pH 7.4
Hepes 260.3 0.2M 4.766 g, pH 7.4 100 mis
TRIS base 121.1 50 mM 6.05 g pH 9.4 with HC1 1000
mis
'With' Ca/Mg buffer
Name Qty of Stock Soln. Notes











Name Qty of Stock Notes
Soln.










Add on day of use
Add on day of useEGTA
Final Vol
Coating IgG plates
Bacteriologic plastic petri dishes (100x15mm) were coated with IgG solution: 5mg IgG
(rat serum, reagent grade, Sigma-Aldridge Ltd, Poole, Dorset, UK) into lOmls of 50mM
tris buffer (pH 9). IgG is allowed to come up to room temperature before weighing.
3. Filter sterilise (pass solution through 0.2 m Millipore filter).
4. Place 5mls of IgG solution into each petri dish.
5. Leave in tissue culture hood at room temperature for 1-3 hours (can turn dishes
occasionally to ensure even coating).
Standard cell culture medium.
Dulbecco's Modified Eagles Medium (Sigma-Aldridge Ltd, Poole, Dorset, UK) with
lOmls, 10% Foetal calf serum 500/<ls, 1% L-Glutamine, 100//1, 1% Penicillin G (10,000
units per ml)/Streptomycin sulphate (10,000 pig per ml) 100/<1 (Gibco).
Solutions for immunohistochemistry:
Blocking Buffer (BB): 2.2g fish skin gelatin per 500mls of 20% Goat serum solution
(in PBS).
BB + triton (BBT): 1ml BB with 10pi\ of 10% triton (in PBS) solution.
Appendix A ii
4% paraformaldehyde: 4g Paraformaldehyde in 100 mis of CMF PBS, heat on hot
plate in fume cupboard at 70°C until dissolves (30 mins). Store at 4°C (or aliquot and
freeze if storing for significant period i.e. months). Filter.
30% Sucrose solution: 15g sucrose in 50 mis PBS. Filter.
Appendix A iii
Appendix B: Published work arising from thesis
Coexpression of RTI40 with alveolar epithelial type II cell proteins in lungs
following injury: identification of alveolar intermediate cell types
Appendix B i
Am J Physiol Lung Cell Mol Physiol 289: L382-L390, 2005.
First published April 22, 2005; doi: 10.1152/ajplung.00476.2004.
Coexpression of RTI40 with alveolar epithelial type II cell proteins in lungs
following injury: identification of alveolar intermediate cell types
Gareth R. Clegg,1* Christine Tyrrell,1* Stuart R. McKechnie,1
Michael F. Beers,2 David Harrison,1 and Mary C. McElroy1
1Edinburgh Medical Research Council Centre for Inflammation Research, University of Edinburgh, Scotland, United Kingdom; and
2University of Pennsylvania Medical Center, Pulmonary, Allergy, and Critical Care Division, Philadelphia, Pennsylvania
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Clegg, Gareth R., Christine Tyrrell, Stuart R. McKechnie,
Michael F. Beers. David Harrison, and Mary C. McF.lray. Com¬
pression of RT14o with alveolar epithelial type II cell proteins in lungs
following injury: identification of alveolar intermediate cell types.
Am J Physiol Lung Cell Mol Physiol 289: L382-L390, 2005. First
published April 22, 2005; doi'AOA 152/ajp/nng.00476.2004.—Injured
alveolar epithelial type (AT) / cells are replacedfollowing the prolif¬
eration and transformation ofATII cells to new A TI cells. RTI40 is an
ATI cell-specific protein required for normal lung development. We
hypothesized that intermediate cell types in the ATIl-to-ATI cell
transformation would coexpress RTI40 and AT// cell-selective pro¬
teins To test this hypothesis, we used a rat model of Staphylococcus
aureus-induced acute lung injury and a panel of ATI and AT//
cell-specific and -selective antibodies. S. aureus induced an acute
inflammatory reaction that was resolving by day 3 postinoculation. A t
day 3 postinoculation, the alveolar wall was thickened secondary to
AT//cell hyperplasia. With the use of confocal microscopy, there was
a fivefold increase in the fractional surface area of alveolar walls
stained with A Til cell membrane proteins (RTII-10 and MMCA) and a
decrease in the fractional surface area associated with RTUo-express-
lug cells. S. uuieus-treated lungs ulso contained unique cell types ihui
coexpressed the RTI40 and AT// markers RTI40/MMCA/RTID0- and
RTI40/MMCA-positive cells. These cells were not observed in control
lungs. RTIWIMMrd-pnsjtive cells were also found in cultured AT//
cells before they transformed to an ATI-like phenotype. Our data
suggest that RTImJMMCA/RTIIin- and RThcJMMCA-positive cells
are intermediates in the ATII-to-ATl cell transformation. These data
also suggest that the coexpression of PT/40 with AT// cell proteins
may be used to identify and investigate AT// cell transdifferentiation
to ATI cells following injury.
Staphylococcus aureus; aquaporin-5; MMCA antigen
the alveolar epithelium in normal lungs is composed of two
ultrastructurally distinct cell types, alveolar epithelial type I
and II cells (ATI and ATII cells). ATI cells are large, thin cells
that together cover 97% of the internal surface area of the lung
(34). ATI cells are important for gas exchange, alveolar fluid
regulation, and stretch-induced modulation of surfactant secre¬
tion (2, 20, 30). Cuboidal ATII cells are located between ATI
cells (34). ATI I cells contain characteristic lamellar bodies in
their cytoplasm and apical microvilli (35). ATII cells have
many known functions, including synthesis and secretion of
lung surfactant, fluid transport, and host defense (13).
ATII cells are also required for alveolar epithelial repair (1,
10, 11, 33). After injury, ATII cells proliferate, and a subset of
* G. R Clegg and C. Tyrrell contributed equally to this work.
Address for reprint requests and other correspondence: M. C. McElroy,
Edinburgh MRC Centre for Inflammation Research, Univ. of Edinburgh,
Teviot Place, Edinburgh EH8 9AG, Scotland, United Kingdom (e-mail:
mary.mcelroy@ukonline.co.uk).
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daughter cells transform to new ATI cells (1, 10, 11, 33).
Ultras true tural studies demonstrated that the formation of ATI
cells is preceded by the presence of intermediate cell types
characterized as ATII- or ATI-like (10, 19). However, we
know little about the mechanism of ATI formation following
injury because of the difficulties in both identifying and quan¬
tifying intermediate cell types by electron microscopy.
ATI and ATII cells can be distinguished by the expression of
selective proteins (6, 16, 24, 36). These proteins can be used to
inform the differences in ATII and ATI cell biology, and as
tools to investigate alveolar epithelial injury and repair in
response to toxic agents (23). Intermediate cells in the ATII-
to-ATI cell transition have been identified based on the coex¬
pression of an ATI cell-associated lectin and the ATII cell-
sclectivc protein surfactant protein (SP) D during the rcsolu
tion of keratinocyte growth factor (KGF)-induced ATII cell
hyperplasia (14).
RTI40 or tla protein is a membrane protein expressed
selectively on the apical surface of ATI cells in the lung (8, 31).
The function of RTI40 is not known, although it is required for
ATI cell morphogenesis during lung development (29). We
hypothesized that alveolar epithelial intermediate cell types
coexpress RH40 and ATII cell-specific or -selective proteins.
We tested this hypothesis in a rat model of Staphylococcus
aureus-induced lung injury (22), using the monoclonal anti¬
body raised by Dobbs and colleagues (8) to detect RTI40. To
identify ATII cells, we used antibodies against apical mem¬
brane proteins: RTII70 (rat type II cell, mol wt 70 kDa) (7) and
the MMC4 antigen (clone name M McElroy 4) (5, 15).
Here we demonstrate the presence of epithelial cells that
coexpress both ATI and ATII cell proteins (that is, RH40,
RTII70, and MMC4) in lungs following S. aureus-induced
injury. In addition, we detect RTUo/MMGI-positive cells in
cultured ATII cells as they become ATI-like. We propose that
the coexpression of RTI40 with ATII cell membrane proteins is
a morphology independent method to identify and study ATII
transformation to new ATI cells in vivo.
MATERIALS AND METHODS
S. aureus. S. aureus, strain 8325-4, was prepared from glycerol
rrockr as described previously (22).
S. aureus-induced lung injury. Rats (specific pathogen-free
Sprague-Dawley males, 300-350 g; Harlan, UK) were anesthetized
with an intraperitoneal injection of fentanyl chloride (1 mg/kg) and
fluanisonc (33 mg/kg) mixed with midazolam hydrochloride (17
mg/kg). Once the rats were anesthetized, S. aureus (108 colony
forming units) was instilled into the distal airways as previously
described (22). Control rats were instilled with PBS. The lungs were
examined at days 3, 5, 7, and 21 post-S. aureus orpost-PBS instilla¬
tion. All animal experiments had the prior approval of the University
http://www.ajplung.org1040-0605/05 $8.00 Copyright © 2005 the American Physiological Society
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of Edinburgh Ethical Review Committee and the Home Office and
were carried out according to the A nimals (Scientific Procedures) A ct,
1986.
Collection of bronchoalveolar lavage fluid. A t day 3 postinstilla-
tion, PBS instilled lungs (n ~ 4) and S. aureus instilled lungs (n = 4)
were lavaged twice with PBS as described previously. Bronchoalveo¬
lar lavage (BA L) fluid was centrifuged (1,000 rpm X 10 min), and the
supernatant was retained for determination of total protein and RTI40
concentrations. The cell pellets were used to determine the total and
differential cell counts as described previously (22). The volume of
BAL fluid recovered from S. aureus-treated lungs was not different
from PBS treated lungs (data not shown). Data are presented as the
total number of cells, protein, and RTI40 recovered in BAL fluid.
Lung homogenization. At day 3 postinstillation, after lavage, S.
aureus-instilled lungs were removed, and the inflamed and nonin-
flamed regions were homogenized separately as previously described
(n - 4) (22). The PBS ■instilled lungs (controls) were normal in
appearance and were therefore homogenized whole (n = 4). The
protein concentration of homogenized lungs was determined using a
Bio-Rod protein assay.
ELISA-based dot blot analysis. The amount of the MMC4 and
RTLo proteins in BAL fluid and lung homogenates was quantified
using ELISA based dot blot assay as previously described (5, 26).
Western blot analysis. Lung proteins were resolved on 12% Nw-
PAGE Bis Tris (\bis (2 hydwxycthyl) amino] tris (hydroxymethyl)
methane] Gels Electrophoresis System (lnvitrogen, Paisley, UK) and
electrophoretically transferred to polyvinylidene difluoride membrane
(Immobilon-P) using the NuPAGE transfer buffer. Membranes were
blocked in 2.5% casein in Tris-buffered saline (10 mM Tris-HCl and
0.15 M NaCV, pH 8.2) and developed as for the ELISA-based dot
blots. A nti-RTIm was detected using an anti-mouse IgG horseradish
peroxidase (1 in 2,000 in blocking buffer, Rockland Immunochemi¬
cals). Aquaporin-5 (Chemicon International, 1 in 100 in DMEM +
10% FCS) was detected with anti-rabbit IgG horseradish peroxidase
(either 1 in 1,000 or 2,000 dilution in blocking buffer, Rockland
Immunochemicals). The optical density of Western blot bands was
determined using a gel documentation and analysis system (U\P
GDS7600).
Electron microscopic analysis. A t day 3 postinstillation, PBS- (n =
2) and S. aureus-treated lungs (n = 2) were fixed and processed for
electron microscopy as described previously (22).
Lung fixation for paraffin sections. A t day 3 (n = 4), day 5 (n = 3),
day 7 (n — 2), and day 21 (n — 3) posiinstillaiion, PBS- and S.
aureus-treated lungs were fixed in formalin. Sections were stained
with hematoxylin and eosin.
Lung fixation for confocal microscopy. A t day 3 postinstillation,
PBS- (n = 3) and S. aureus- (n = 3) treated lungs were fixed with 4%
paraformaldehyde for 2 h. Small cubes from the macroscopically
inflamed lobes were selected and cryopwtected overnight in 30%
(wtlvol) sucrose. Frozen sections were cut the next day as previously
described (5, 22).
Immunostaining. Frozen lung sections and cultured alveolar epi¬
thelial cells were incubated with various cocktails of primary anti¬
bodies followed by isotype- or species-specific secondary antibodies
(Molecular Probes, Leiden, Netherlands) as described previously (5,
Table 1. All and ATI I cell-specific or selective proteins
Alexa Fluor Anti-
Mouce Secondary
Name Cell Specificity Isotype Antibodies
MMC4 MAb ATII and Clara IgG2a 546 (red)
Anti-RXlL/o ATII IgG3 647 (blue)
Anti-RTLio ATI IgGi 488 (green)
Anti-aquaporin-5 ATI and Clara cells Rahbit polyclonal Western blot only
AH and ATH alveolar epithelial types I and n, respectively.
22) (Table 1). The nucleus was stained with the DNA probe To-Pro-3
(Molecular Probes).
Cnnfora! imaging and analysis. Fluorescent images were acquired
using a Zeiss Axiovcrt LSM 510 confocal microscope. AlexaFluor
488 (green) was imaged with an excitation wavelength of 488 nm.
AlexaFluor 546 (red) was imaged at 543 nm. Alexa 647 (blue) was
imaged at 633 nm. The sections were sequentially scanned at different
excitation wavelengths to ensure discrimination between the overlap¬
ping fluorescent spectra of A lexa dyes 488 and 546.
For quantification a computer-controlled motorized stage was used
to obtain tiled images consisting of 16 (4 X 4) high powered (X63
objective) contiguous fields combined into a suiglt red, gittn, and
blue T/FF file. Openlab 3.5.1 analysis software (Improvision) was
used to create a binary mask consisting of the positively stained areas
in each separate color channel; binary masks were combined to
identify areas of rolacalizatinn. To determine the length of a posi¬
tively stained wall for a given color or combination of colors, binary
masks were overlaid on the corresponding transmitted light image,
and the length of the positively stained alveolar wall was traced and
measured using a graphics tablet (W.4 COM Technology). Data arc
reported as the percentage of alveolar wall stained with a given
antibody.
For three-dimensional viewing of alveolar wall membranes, con¬
focal scanning was carried out using Nyqittsf settings. The raw data
were deconvoluied using Huygens 2 (SVI) software and reatnsirut tetl
and analyzed for colocaHzation using Imwis 4.0 software (Bitplcuie,
Zurich, Switzerland) (9).
ATII cell isolations. Type II cells were isolated from the lungs of
male Sprague-Dawley specific pathogen-free rats (Harlan) using pre¬
viously described methods (5, 8) (n = 3 isolations). ATII cells were
fixed in 4% paraformaldehyde at days 0, 1, and 5. The A Til cells were
75% pure immediately following isolation; contaminating cells in¬
cluded macrophages, lymphocytes, and ATI cells (RTl^rpositive
cells accounted for ~ 1% of the total cells).
Statistics. Data are expressed as means (SD). Comparison between
samples was analyzed using Student's t-test. P < 0.05 was considered
significant. Tests were performed with GraphPad Instat version 3.0a.
RESULTS
General liisiology of S. aureus-instilled lungs, day 3 to day
21 postinstillation. At day 3 postinstillation, the alveolar walls
from inflamed regions of S. aureus instilled lungs were thick
ened compared with the alveolar walls in the noninflamcd
regions and control lungs (Fig. 1). The numberof inflammatory
cells present in the air spaces was also increased in S. aureus
instilled lungs (Fig. 1). By day 7 postinstillation, S. aureus-
treated lungs were almost normal; the alveolar walls were
thinner and there were fewer inflammatory cells in the air
spaces (Fig. 1). By day 21, S. aureus-inoculated lungs were
indistinguishable from control lungs (data not shown).
Ultrastructure of the alveolar wall at day 3 post-S. aureus
instillation. The thickened alveolar walls in S. aureus instilled
lungs were due to increased numbers of ATII cells (i.e., cells
containing lamellar bodies and apical microvilli) or cuboidal
epithelial cells with, and without, some ATII cell ultrastruc-
tural features (that is, ATII-like cells). ATII-like cells included
cells with apical microvilli and lamellar bodies but reduced
perinuclear cytoplasm, cells with apical microvilli and no
lamellar bodies, and cells with no apical microvilli or lamellar
bodies (Fig. 2). In addition, ATI cells were also observed
overlaying ATII cells (Fig. 2). The alveolar epithelium in the
noninstilled region from S. aureus-itistilled lungs was tire same
as shown previously for control lungs (data not shown).
A/P-Lung Cell Mol Physiol • VOL 289 • SEPTEMBER 2005 • www.ajplung.org
L384 rti40 alveolar epithelial repair
Fig. 1. Hematoxylin and eosin-stained lung
sections from control and Staphylococcus
aureus-injured lungs are shown. A control
lung shows a characteristic mesh of air
spaces (*) bounded by thin alveolar walls. B:
at day 3 post-S. aureus instillation, there is
an intense inflammatory infiltrate (arrows).
Remaining air spaces (black asterisk) have
thickened walls. In consolidated areas, the
alveolar air space is obliterated (white aster¬
isk). C: at day 5 post-S. aureus instillation,
there are less inflammatory cells in the air
spaces (arrows), although the alveolar walls
are still thicker than control lungs. D: by day
7 post-S. aureus instillation, only occasional
inflammatory cells are observed in the air
spaces (arrows), and the alveolar wall ap¬
pears normal. E: boundary between an area
of normal looking noninflamed lung and an
area of inflamed tissue at day 3 post-S. au¬
reus instillation (arrows).
Alveolar barrier injury and inflammation on day 3 post-S.
aureus instillation. At day 3 post-S. aureus instillation, the
total amount of protein recovered in BAL fluid was elevated
1.6-fold above control values (i.e., 3.03 ± 0.89 mg vs. 1.87 ±
0.43 mg, P < 0.05, n = 3). In contrast, our previous study
demonstrated that the total amount of protein recovered in
BAL fluid was elevated 6.8-fold at day I post-S. aureus
instillation compared with control values (22).
The total number of BAL leukocytes was elevated 2.5-fold
above control values (i.e., 8.33 X 105 ± 1.95 X 10s vs. 3.53 X
105 ± 0.37 X 105, P < 0.05, n = 3) at day 3 post-S. aureus
instillation. In contrast, the total number of leukocytes recov¬
ered in BAL fluid was elevated 57-fold above control values at
day 1 post-S. aureus instillation (22).
The amount of RTLo recovered in BAL fluid can be used to
assess the extent of ATI cell necrosis (25, 26). The amount of
RTLo recovered in BAL fluid at day 3 postinstillation was not
different from control values (data not shown).
These protein and inflammatory cell data confirm the acute
inflammatory response to S. aureus is resolving by day 3
postinstillation, and there is no evidence of ATI cell necrosis.
Concentration of RTLo, aquaporin-5, and the MMC4 anti¬
gen in lung homogenates at day 3 post-S. aureus instillation.
The concentration of RTLo was decreased by > 18-fold in lung
homogenates from the inflamed regions of S. aureus-inocu-
lated lungs compared with control lungs (Fig. 3). Similarly, the
concentration of aquaporin-5, expressed by ATI cells and
nonciliated bronchiolar epithelial cells (27), was decreased by
fivefold in inflamed regions from S. aureus-inoculated lungs
compared with control lungs (Fig. 3). However, in the nonin¬
flamed regions, the concentration of RTLo was not different
from control values, whereas the concentration of aquaporin-5
was increased by nearly twofold (Fig. 3).
The concentration of the MMC4 antigen was increased in
lung homogenates from the inflamed region of S. aureus
treated lungs compared with control values, whereas in the
noninflamed region of S. aureus-instilled lungs, the concentra¬
tion of MMC4 antigen was not different from control values
(Fig. 3).
Phenotype of the alveolar epithelium in control lungs. The
antibodies used here have been shown previously to bind
selectively to ATI or ATII cells (Table 1). Here we demon-
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strati- that these antibodies can be used in combination to
investigate the phenotype of ATI and ATII cells simulta¬
neously. RTI40 is expressed on the apical surface of ATI cells,































Fig. 2. Electron micrographs of alveolar epithelial cells in S. aureus-injured
lungs at day 3 postinstillation are shown. A: flattened epithelial cell containing
microvilli (arrowheads) and lamellar bodies (LZ?) but with reduced perinuclear
cytoplasm. Original magnification, X6,700. B: group of cuboidal epithelial
cells with reduced cytoplasm and numbers of LB but with microvilli (arrow¬
heads). Original magnification, X5,000. C: alveolar epithelial type (AT) I cell
overlaying an ATH cell. Inset demonstrates the presence of a membrane
between the 2 cell types. Original magnification, X 1,000; for inset, X 125,000.
Ctrl N-lnflnf
MMC4
Fig. 3. Concentration of RTLto, aquaporin-5, and the MMC4 antigen in lung
homogenates from control and S. aureus-injured lungs at day 3 postinstillation.
Western blots were performed as described in materials and methods.
Protein (10 p,g) was loaded per lane. Each lane represents a different lung
sample. A: Western blot demonstrates RTI40 is downregulated in lung homog¬
enates from inflamed lungs (Inf) compared with controls (Ctrl) and the
noninflamed regions (N-Inf). B: Western blot demonstrates aquaporin-5 is
downregulated in lung homogenates from inflamed lungs but upregulated in
noninflamed regions compared with control values. C: quantitative changes in
the concentration of RTI40 and aquaporin-5. D: concentration of the MMC4
protein was increased in inflamed regions compared with values from controls
and from noninflamed regions (data obtained using an ELISA-based dot blot
assay). Data in C and D are shown as means (SD). Values significantly
different from control values are shown (data analyzed using ANOVA). NS,
not significant; RDU, relative densitometry units.
of ATII cells (Fig. 4) (5, 7, 8). The relative proportion of
alveolar surface area occupied by ATI to ATII cells, assessed
by measuring the fractional surface area of the alveolar wall
associated with RTLo and RTH7o/MMC4 staining, was 97.0%
vs. 2.5% (a ratio of 39:1) (Fig. 4). This ratio is identical to the
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ratio of 39:1 obtained from measurements made from electron
micrographs of rat lungs and suggests that RTII70/MMC4
coexpression identifies most ATII cells (18).
Phenotype of the alveolar epithelium at day 3 post-S. aureus
instillation. As in control lungs, the alveolar walls in the
inflamed regions were lined by both RTl40-positive cells (ATI
cells) and MMC4/RT1bo-positive cells (ATII cells) (Fig. 4).
However, the fractional surface area covered by MMC4/
RTlbo-positive cells (ATII cells) was increased by more than
fivefold in S. aureus-injured lungs compared with control lungs
(Fig. 4). The MMC4 monoclonal antibody also stained ED1-
positive cells (a macrophage marker) in the air spaces (data not
shown); this is consistent with our observation that the MMC4
monoclonal antibody binds to aminopeptidase N (15). The
fractional surface area covered by RTI40 (ATI cells) in S.
aureus-injured lungs was significantly decreased compared
with control lungs (Fig. 4). The fractional surface area ratio of
ATI to ATII cells decreased from 39:1 in control lungs to —7:1
in S. aureus-instilled lungs (Fig. 5).
In regions with thickened alveolar walls and hyperplastic
ATII cells, we observed RTbo/RTIbo/MMCM-postive and
RTI4()/MMC4-positive alveolar membranes (Figs. 4 and 6).
Three-dimensional analysis of RTl4o/MMC4-coexpressing
membranes, with deconvolution, confirmed coexpression of
these proteins on the same membrane (Fig. 7). Quantitative
analysis demonstrated that RTUo/MMObpositive membranes
in S. aureus-injured lungs accounted for —3% of the fractional
alveolar surface area in the inflamed region (Fig. 5). RTI4(>/
MMC4-positive cells, which also expressed RTII70, accounted
for one-third of this percentage. The average length of RTI40/
MMC4-positive membranes in S. aureus treated lungs was
13.6 ± 11.4 p,m (n = 3) compared with an average length of
7.2 ± 0.7 pm for ATII cells in control lungs.
The small area of RTl4o/MMC4-coexpressing epithelium in
control lungs (0.1%) was limited to areas where ATI cells
(RTUo-positive) and the apical membrane of ATII cells
(MMC4/RTll7o-positive) were adjacent These areas are likely
to represent the interface of separate red- and green-staining
membranes within the same voxel rather than coexpression on
the same membrane (Fig. 7).
Phenotype of cultured ATII cells. Primary ATII cells rapidly
lose ATII characteristics and gain some ATI-like characteris¬
tics in culture. Specifically, cuboidal ATII cells spread and
Fig. 4. Expression of ATI and ATE cell-selective markers in control and S.
aureus-injured lungs is shown. Lung sections (5-7 pm thick) were incubated
with antibodies as described in materials and methods and imaged using
confocal microscopy. A control lung, individual channels, and merged image
demonstrating MMC4 (red) and RTTLo (blue) are coexpressed on an alveolar
epithelial cell located between RTLo-positive cells (green), fiar = 10 pm. B:
lower magnification of control lung demonstrating MMC4/RTII70 colocaliza-
tion (pink cell, arrowhead). RTI40 staining is shown in green (arrow). Corre¬
sponding transmitted image is also shown. Bar = 25 pm. C: S. aureus-injured
lung on day 3 postinstillation. Image demonstrates that the surface area of
alveolar walls coexpressing the ATII cell markers MMC4/RTII70 is increased
compared with control lungs (purple cells, arrowheads). Whereas the alveolar
surface is covered by the ATI cell marker, RTT40 is decreased compared with
control lungs (green, thick arrows). Some alveolar membranes are stained with
a new combination of MMC4 (red) and RTT40 (green) to generate yellow
membranes (thin arrow). Image also demonstrates that monocytes/macro-
phages in the air spaces express the MMC4 antigen, flar = 25 pm. D: higher
magnification and individual channels of RTl4o/MMC4-positive membranes
seen in C.









Fig. 5. Shown is the percentage of the alveolar wall covered by ATI and ATE
cell markers in S. aureus-injured and control lungs. Images are captured and
analyzed as detailed in materials and methods. The total epithelial surface
measured in control and S. aureus-treated lungs was 16,063 ± 3,058 p,m and
15,783 ± 1,203 |xm, respectively. A ATI cells (RTLio-positive membranes). B:
ATE cells (RTB7o/MMC4-coexpressing membranes). C: alveolar intermediate
cells (RTl4o/MMC4-coexpressing membranes).
flatten and lose lamellar bodies (4, 8). While accompanying
these morphological changes, AT11 cells stop expressing ATII
proteins (for example, SP and RTII70) and express some ATI
cell-associated proteins such as RTLo and aquaporin-5 (4, 6, 8,
16). Unlike most previous studies, we followed this transition
by examining the phenotype of alveolar epithelial cells in
culture. We demonstrated that freshly isolated ATII cells
coexpressed RTII70 and MMC4 but not RTI40 (Fig. 8). By day
5 in culture, cells expressed RTI40 but not RTII70 or MMC4
(Fig. 8). However, on day 1, although most cells were negative
or slightly positive for RTI40, some cells (5.9 ± 1.4%, n = 3)
coexpressed RTI40 and MMC4 (Fig. 8). We did not detect
RTII70 at day 1 of culture.
DISCUSSION
In a previous study we demonstrated that S. aureus induced
an inflammatory reaction at day 1 postinstillation (22). Here we
demonstrate at day 3 post-S. aureus instillation that general
markers of acute inflammation (i.e., total number of BAL fluid
leukocytes) and alveolar wall damage (as assessed by total
amount of protein in BAL fluid) are returning to control values.
Using morphological methods, we also demonstrate that S.
aureus instillation induced a localized inflammatory reaction,
probably at the initial site of bacterial deposition. By day 3
postinstillation, the lungs are easily separated into noninflamed
and inflamed regions. The inflamed regions have a markedly
thickened alveolar wall secondary to ATII cell hyperplasia.
The noninflamed regions appear normal. After S. aureus
induced acute lung injury, ourmorphological data indicate that
the lungs are normal by day 21.
To characterize the regional nature of S. aureus-induced
ATII cell hyperplasia, we analyzed the concentration of ATI
and ATII cell-specific and -selective proteins in inflamed and
noninflamed regions at day 3 postinstillation. The concentra¬
tion of both ATI cell proteins (e.g., RTI40 and aquaporin-5)
were specifically decreased in inflamed regions from S. aureus-
injured lungs. This result is consistent with a decrease in the












Fig. 6. Comparison of RTl4o/MMC4-positive membranes in control and S.
aureus-injured lungs following deconvolution is shown. Deconvoluted images
were restored in 3 dimensions and then subjected to an object-independent
extraction of red (MMC4 expression) and green (RH40 expression) colors
using Colocalization 2.0 (Zritplane) software. Colocalized voxels are shown in
yellow. A RTLu)/MMC4 coexpression in the control lung. Colocalization of
red and green voxels (yellow) were limited to the junction between RTI40- and
MMC4-positive cells in both the x, y, and z, y dimensions. An MMC4-positive
cell surrounded by an RTLw-positive cell with colocalization (in yellow) was
limited to areas at the junction between RTL«)/MMC4-positive cells. B:
RH40/MMC4 coexpression in S. aureus-injured lung. In contrast with control
lung, colocalization of red and green voxels (yellow) extend across the surface
of the alveolar wall in both the x, y, and z, y, dimensions.





decreased ATI cell numbers, or fractional surface area, follow¬
ing S. aureus-induced acute lung injury.
Using a panel of ATI and ATI I cell-specific and -selective
antibodies, we investigated the phenotype of the alveolar
epithelium following S. aureus-induced acute lung injury at
day 3 postinstillation. As in controls, the alveolar walls in
inflamed regions were lined with RTIl7o/MMC4-positive cells
(ATI I cells) and RTUo-positive cells (ATI cells). However, the
fractional surface area covered by RTI17o/MMC4-positive cells
was significantly increased compared with control lungs, in¬
dicative of ATII cell hyperplasia RTII7o/MMC4-postive cells
in S. aureus-injured lungs were not uniformly positive for
Fig. 7. Coexpression of RTI40, MMC4, and RTII70 on alveolar membranes in
S. aureus-injured lungs. An area of the alveolar wall from S. aureus-instilled
lung shows MMC4/RTI40 coexpression (arrow) adjacent to an area ofMMC4/
RTLMj/RTEbo coexpression (arrowheads). Separate and merged confocal im¬
ages are shown as well as the corresponding transmitted image. Bar = 10 |xm.
numberof ATI cells, and/or a decrease in the fractional surface
area of ATI cells, secondary to ATII cell hyperplasia. In the
noninflamed regions, the concentration of aquaporin-5 was
upregulated relative to control values. In contrast, aquaporin-5
is downregulated in regions without overt inflammation (non-
inflamed) in an experimental model of viral pneumonia (32).
Our attempts to demonstrate increased numbers of ATII
cells by measuring the concentration of ATII cell-specific and
-selective proteins were less clear-cut than for the ATI cell
proteins. By Western blot analysis, the concentration of pro-
SP-C, expressed by ATII cells (3, 21), was not different from
control values (data not shown). Potential reasons could in¬
clude a nonhomogeneous regulation of SP-C expression that
could occurwith foci of both upregulation and downregulation
in different areas of inflammation and of proliferative repair
(hyperplasia) known to occur in these lungs. Interestingly, the
concentration of SP-D, expressed by ATII cells and Clara cells
(26), was elevated in both inflamed and noninflamed regions
(data not shown) and was most likely influenced by the
complex regulation of this protein by a variety of cytokines and
mediators. The concentration of the MMC4 protein, however,
was selectively elevated over the concentration of MMC4
protein in noninflamed regions; this may in part be represen¬
tative of ATII cell hyperplasia. In general, only the concentra¬
tion of the ATI cell proteins, and the MMC4 antigen, revealed
the regional nature of S. aureus-induced injury and supported














Fig. 8. Expression of ATI and ATD cell-selective proteins in cultured alveolar
epithelial cells is shown. A freshly isolated Am cells coexpress RTH70 (blue)
and the MMC4 antigen (red). A merged image is shown. Bar = 10 p.m. B: by
7 days in culture, alveolar epithelial cells are spread out and express RTL10 but
not RTIEo or the MMC4 antigen. A merged image is shown. Bar = 10 (im. C:
on day 1 of culture, some cells coexpress RH40 and the MMC4 antigen
(arrow). Some flattened and spreading cells are slightly positive for RTI40
(arrowheads). Separate channels, merged image, and corresponding transmit¬
ted images are shown. Bar = 10 p,m.
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pro-SP-C (data not shown). These data suggest that RTH70/
MMC4-postive cells may recognize both the ATII- and ATII-
like cells, with few or no lamellar bodies, seen by ultrastruc-
tural analysis of the lungs.
In regions associated with increased numbers of RTII70/
MMC4-positive cells, we observed membranes that coex-
pressed ATI and ATII cell proteins, RTI40, MMC4, and RTII70.
RTI40/MMC4 cells were the most abundantly mixed pheno-
type. We did not observe RTl4o/MMC4-positive alveolar wall
cells in the noninstilled regions from S. aureus-instilled lungs
or control lungs. Our ultras truetural studies demonstrated that
some ATI cells overlay ATII cells following injury. Alveolar
epithelial multilayering has been previously described follow¬
ing a range of different toxic stimuli [for example, nitrogen
dioxide (11), Freund's adjuvant (12), and nitric acid (17)]. To
rule out the possibility that areas of RTI40/MMC4 coexpression
were secondary to ATI cells overlaying ATII cells, confocal
images were subject to deconvolution and increasing image
resolution, particularly in the z-plane. Deconvoluted images
confirmed the coexpression of RTI40 and MMC4 on the same
membrane.
Intermediates in the ATII to ATI cell transformation have
multiple ultras true tural phenotypes ranging from ATII cells
spreading out over the basement membrane to ATI cells with
occasional microvilli and dense inclusions (10, 19). It is there¬
fore possible that we have phenotyped two intermediate cell
types based on the coexpression of RTI40 with various ATII
cell markers. Early intermediate cell types may coexpress
RTI4(/MMC4/RTI 170, whereas later intermediates may coex¬
press RTI40/MMC4. Additionally, RTI40/MMC4-positive cells
were found on average to have a luminal surface length twice
that of ATII cells (i.e., 13.6 p,m vs. 7.40 pm), suggesting that
these cells are in the process of becoming attenuated and
flattened ATI cells.
Cultured ATII cells rapidly loose ATII cell phenotypic
characteristics and gain ATI cell-like characteristics. We dem¬
onstrated that RTIt(/MMC4-positive cells could be detected in
cultured ATII cells before they become ATI cell-like. These in
vitro data additionally suggest that RTl4()/MMC4-positive cells
are kinetically competent to be intermediate cell types.
Others have also described putative intermediate cell types
based on the coexpression of ATI and ATII cell markers (14).
Fehrenbach and colleagues (14) demonstrated that the ATI cell
lectin Lycopersicon esculentum agglutinin and SP-D were
coexpressed on alveolar epithelial cells following KGF-in-
duced ATII cell hyperplasia However, given that alveolar
epithelial cells tend to overlay ATII cells in many lung injury
models, coexpression of a membrane (e.g., lectin) and cyto¬
plasmic marker (e.g., SP-D) would not distinguish between
multilayering and potential intermediate cell types. Coexpres¬
sion of ATT- and ATII-selective membrane proteins is there¬
fore more likely to identify intermediate cell types in the lung
following injury.
In summary, we have characterized the phenotype of the
alveolar epithelium in a rat model of focal acute lung injury
caused by distal airway instillation of S. aureus. Our data
demonstrate that in inflamed lung, there are increased numbers
of ATII cells (defined by RTII70/MMC4 coexpression) and
reduced ATI cell numbers or surface area (defined by RTI40
expression). Within these regions, we observed alveolar epi¬
thelial cells that coexpressed RTI40, RTII70, and MMC4. These
coexpressing cells were not seen in control lungs or in the
noninflamed regions from S. aureus-instilled lungs. However,
RTl4o/MMC4-positive cells were observed in vitro as ATII
cells transformed to ATI-like cells. These data suggest that the
coexpression of RTI40 with ATII cell proteins, such as RTII70
and MMC4, may be used to detect ATII cells in the process of
transforming to new ATI cells and therefore provides a means
of investigating the mechanism of ATI cell formation follow¬
ing injury.
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